// Auto-generated - do not edit
export const substanceName = "Cocaine";
export const sources = [{"id":"drugbank","fileName":"DRUGBANK - Cocaine.md","displayName":"DrugBank","size":22211},{"id":"drugusersbible","fileName":"DRUGUSERSBIBLE - Cocaine.md","displayName":"Drug Users Bible","size":11002},{"id":"protestkit","fileName":"PROTESTKIT - Cocaine.json","displayName":"Protest Kit","size":5459},{"id":"saferparty","fileName":"SAFERPARTY - Cocaine.md","displayName":"Safer Party","size":7309},{"id":"tripsit-factsheets","fileName":"TRIPSIT_FACTSHEETS - Cocaine.md","displayName":"TripSit Factsheets","size":6232},{"id":"wikipedia","fileName":"WIKIPEDIA - Cocaine.md","displayName":"Wikipedia","size":68937}];
export const contents: Record<string, string> = {
  "drugbank": `# Cocaine
*Source: https://go.drugbank.com/drugs/DB00907*

## Overview

### Description

This compound belongs to the class of organic compounds known as benzoic acid esters. These are ester derivatives of benzoic acid.

### Background

An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.

### Indication

For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.

### Pharmacodynamics

Cocaine is a local anesthetic indicated for the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.

### Mechanism of Action

Sodium-dependent dopamine transporter
Inhibitor
Sodium-dependent noradrenaline transporter
Inhibitor
Sodium channel protein
Inhibitor
+ 1 more target

### Absorption

Cocaine is absorbed from all sites of application, including mucous membranes and gastrointestinal mucosa. By oral or intra-nasal route, 60 to 80% of cocaine is absorbed.

### Metabolism

Hepatic. Cocaine is metabolized to benzoylecgonine and ecgonine methyl ester, which are both excreted in the urine. In the presence of alcohol, a further active metabolite, cocaethylene is formed, and is more toxic then cocaine itself.
Hover over products below to view reaction partners
Cocaine
norcocaine
Benzoylecgonine
Cocaethylene

### Half-life

1 hour

### Toxicity

Intense agitation, convulsions, hypertension, rhythm disturbance, coronary insufficiency, hyperthermia, rhabdomyolysis, and renal impairment. Oral mouse LD
50
= 96 mg/kg

### Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Abametapir
The serum concentration of Cocaine can be increased when it is combined with Abametapir.
Abemaciclib
The risk or severity of methemoglobinemia can be increased when Abemaciclib is combined with Cocaine.
Abiraterone
The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Cocaine.
Acebutolol
The metabolism of Acebutolol can be decreased when combined with Cocaine.
Acetaminophen
The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Cocaine.

### Food Interactions

No interactions found.

## Chemical Information

**DrugBank ID:** DB00907

**Synonyms:** (-)-Cocaine
(−)-cocaine
[1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester
2-methyl-3β-hydroxy-1αH,5αH-tropane-2β-carboxylate benzoate (ester)
Benzoylmethylecgonine
beta-Cocain
Cocain
Cocaina
Cocaine
Cocainum
Kokain
L-Cocain
L-Cocaine
methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
Methyl benzoylecgonine
Neurocaine

**Chemical Formula:** C
17
H
21
NO
4

**SMILES:** [H][C@]12CC[C@]([H])([C@H]([C@H](C1)OC(=O)C1=CC=CC=C1)C(=O)OC)N2C

**Weight:** Average: 303.3529
Monoisotopic: 303.147058165

**IUPAC Name:** methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate

## Additional Information

### Modality

Small Molecule

### Patents

Patent Number
Pediatric Extension
Expires (estimated)
Region
US9867815
No
2018-01-16
2037-02-07
US
US10016407
No
2018-07-10
2037-02-07
US
US10149843
No
2018-12-11
2037-02-07
US
US10231961
No
2019-03-19
2037-02-07
US
US10413505
No
2019-09-17
2037-02-07
US
US10420760
No
2019-09-24
2037-02-07
US
US10857095
No
2020-12-08
2037-02-07
US
US10894012
No
2021-01-19
2037-02-07
US
US10933060
No
2021-03-02
2037-02-07
US
US10973811
No
2021-04-13
2037-02-07
US
US10987347
No
2021-04-27
2037-02-07
US
US11040032
No
2021-06-22
2037-02-07
US

### Indicated Conditions

2

### Phase 0

7

### Phase 1

33

### Phase 2

12

### Phase 3

6

### Phase 4

5

### Therapeutic Categories

Anesthetics,
Local
Local Anesthetics
(Ester)

### Summary

Cocaine
is an ester local anesthetic used during diagnostic procedures and surgeries in or through the nasal cavities.

### Brand Names

Goprelto, Numbrino

### Generic Name

Cocaine

### DrugBank Accession Number

DB00907

### Groups

Approved, Illicit, Investigational

### Structure

3D
Download
MOL
SDF
3D-SDF
PDB
SMILES
InChI
Similar Structures
Structure for Cocaine (DB00907)
×
Close

### External IDs

IDS-NC-004
RX-0041
RX0041

### Associated Conditions

Indication Type
Indication
Combined Product Details
Approval Level
Age Group
Patient Characteristics
Dose Form
Create Account

### Mechanism of action

Cocaine produces anesthesia by inhibiting excitation of nerve endings or by blocking conduction in peripheral nerves. This is achieved by reversibly binding to and inactivating sodium channels. Sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. Cocaine is the only local anesthetic with vasoconstrictive properties. This is a result of its blockade of norepinephrine reuptake in the autonomic nervous system. Cocaine binds differentially to the dopamine, serotonin, and norepinephrine transport proteins and directly prevents the re-uptake of dopamine, serotonin, and norepinephrine into pre-synaptic neurons. Its effect on dopamine levels is most responsible for the addictive property of cocaine.
Target
Actions
Organism
A
Sodium-dependent dopamine transporter
inhibitor
Humans
A
Sodium-dependent noradrenaline transporter
inhibitor
Humans
A
Sodium channel protein
inhibitor
Humans
A
Sodium-dependent serotonin transporter
inhibitor
Humans
U
Muscarinic acetylcholine receptor M1
antagonist
Humans
U
Muscarinic acetylcholine receptor M2
antagonist
Humans
U
Sigma non-opioid intracellular receptor 1
agonist
Humans
U
Liver carboxylesterase 1
binder
Humans

### Pathways

Pathway
Category
Cocaine Action Pathway
Drug action

### Product Ingredients

Ingredient
UNII
CAS
InChI Key
Cocaine hydrochloride
XH8T8T6WZH
53-21-4
PIQVDUKEQYOJNR-VZXSFKIWSA-N

### Brand Name Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Cocaine Hydrochloride
Solution
100 mg/1mL
Topical
Lannett Company, Inc.
2008-12-01
2020-08-31
US
Cocaine Hydrochloride
Solution
40 mg/1mL
Topical
Lannett Company, Inc.
2008-12-01
2020-08-31
US
Cocaine Hydrochloride Top Sol 40mg/ml
Liquid
40 mg / mL
Topical
Sandoz S.P.A.
1992-12-31
2019-08-01
Canada
Cocaine Hydrochloride Topical Sol 10%
Liquid
100 mg / mL
Topical
Sandoz S.P.A.
1992-12-31
2019-08-01
Canada
Goprelto
Solution
40 mg/1mL
Nasal
LXO US Inc.
2024-02-09
Not applicable
US

### Generic Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Cocaine Hydrochloride
Solution
40 mg/1mL
Nasal
Genus Lifesciences Inc.
2018-06-04
Not applicable
US
Cocaine Hydrochloride
Solution
40 mg/1mL
Nasal
LXO US Inc.
2024-01-29
Not applicable
US
Cocaine Hydrochloride Nasal
Solution
40 mg/1mL
Topical
OMNIVIUM PHARMACEUTICALS LLC.
2023-10-15
Not applicable
US
Cocaine Hydrochloride Nasal
Solution
40 mg/1mL
Topical
Lannett Company, Inc.
2020-01-10
2024-08-31
US
PMS-cocaine Hydrochloride Topical Sol 10%
Liquid
100 mg / mL
Topical
Pharmascience Inc
1995-12-31
Not applicable
Canada

### Unapproved/Other Products

Name
Ingredients
Dosage
Route
Labeller
Marketing Start
Marketing End
Region
Image
Cocaine Hydrochloride
Cocaine hydrochloride
(100 mg/1mL)
Solution
Topical
Lannett Company, Inc.
2008-12-01
2020-08-31
US
Cocaine Hydrochloride
Cocaine hydrochloride
(40 mg/1mL)
Solution
Topical
Lannett Company, Inc.
2008-12-01
2020-08-31
US

### ATC Codes

S01HA01 — Cocaine
S01HA — Local anesthetics
S01H — LOCAL ANESTHETICS
S01 — OPHTHALMOLOGICALS
S — SENSORY ORGANS
S02DA02 — Cocaine
S02DA — Analgesics and anesthetics
S02D — OTHER OTOLOGICALS
S02 — OTOLOGICALS
S — SENSORY ORGANS
N01BC01 — Cocaine
N01BC — Esters of benzoic acid
N01B — ANESTHETICS, LOCAL
N01 — ANESTHETICS
N — NERVOUS SYSTEM
R02AD03 — Cocaine
R02AD — Anesthetics, local
R02A — THROAT PREPARATIONS
R02 — THROAT PREPARATIONS
R — RESPIRATORY SYSTEM

### Drug Categories

Agents producing tachycardia
Agents that reduce seizure threshold
Alkaloids
Analgesics and Anesthetics
Anesthetics
Anesthetics, Local
Anticholinergic Agents
Aza Compounds
Azabicyclo Compounds
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Stimulants
Cholinesterase substrates
Cocaine, antagonists & inhibitors
Cytochrome P-450 CYP2D6 Inhibitors
Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 Enzyme Inhibitors
Cytochrome P-450 Substrates
Dopamine Agents
Dopamine Uptake Inhibitors
Esters of Benzoic Acid
Highest Risk QTc-Prolonging Agents
Local Anesthetics (Ester)
Membrane Transport Modulators
Muscarinic Antagonists
Nervous System
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
OCT2 Inhibitors
Ophthalmologicals
QTc Prolonging Agents
Sensory Organs
Sensory System Agents
Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
Throat Preparations
Tropanes
Vasoconstrictor Agents

### Chemical TaxonomyProvided byClassyfire

Description
This compound belongs to the class of organic compounds known as benzoic acid esters. These are ester derivatives of benzoic acid.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Benzoic acid esters
Alternative Parents
Tropane alkaloids
/
Piperidinecarboxylic acids
/
Benzoyl derivatives
/
N-alkylpyrrolidines
/
Dicarboxylic acids and derivatives
/
Methyl esters
/
Trialkylamines
/
Amino acids and derivatives
/
Azacyclic compounds
/
Organopnictogen compounds
/
Organic oxides
/
Hydrocarbon derivatives
/
Carbonyl compounds
show 3 more
Substituents
Amine
/
Amino acid or derivatives
/
Aromatic heteropolycyclic compound
/
Azacycle
/
Benzoate ester
/
Benzoyl
/
Carbonyl group
/
Carboxylic acid derivative
/
Carboxylic acid ester
/
Dicarboxylic acid or derivatives
/
Hydrocarbon derivative
/
Methyl ester
/
N-alkylpyrrolidine
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organoheterocyclic compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Piperidine
/
Piperidinecarboxylic acid
/
Pyrrolidine
/
Tertiary aliphatic amine
/
Tertiary amine
/
Tropane alkaloid
show 16 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
tertiary amino compound, tropane alkaloid, methyl ester, benzoate ester (
CHEBI:27958
)
/
Tropane alkaloids, Alkaloids (
C01416
)

### Kingdom

Organic compounds

### Super Class

Benzenoids

### Class

Benzene and substituted derivatives

### Sub Class

Benzoic acids and derivatives

### Direct Parent

Benzoic acid esters

### Alternative Parents

Tropane alkaloids
/
Piperidinecarboxylic acids
/
Benzoyl derivatives
/
N-alkylpyrrolidines
/
Dicarboxylic acids and derivatives
/
Methyl esters
/
Trialkylamines
/
Amino acids and derivatives
/
Azacyclic compounds
/
Organopnictogen compounds
/
Organic oxides
/
Hydrocarbon derivatives
/
Carbonyl compounds
show 3 more

### Substituents

Amine
/
Amino acid or derivatives
/
Aromatic heteropolycyclic compound
/
Azacycle
/
Benzoate ester
/
Benzoyl
/
Carbonyl group
/
Carboxylic acid derivative
/
Carboxylic acid ester
/
Dicarboxylic acid or derivatives
/
Hydrocarbon derivative
/
Methyl ester
/
N-alkylpyrrolidine
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organoheterocyclic compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Piperidine
/
Piperidinecarboxylic acid
/
Pyrrolidine
/
Tertiary aliphatic amine
/
Tertiary amine
/
Tropane alkaloid
show 16 more

### Molecular Framework

Aromatic heteropolycyclic compounds

### External Descriptors

tertiary amino compound, tropane alkaloid, methyl ester, benzoate ester (
CHEBI:27958
)
/
Tropane alkaloids, Alkaloids (
C01416
)

### Affected organisms

Humans and other mammals

### UNII

I5Y540LHVR

### CAS number

50-36-2

### InChI Key

ZPUCINDJVBIVPJ-LJISPDSOSA-N

### InChI

InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1

### Synthesis Reference

Nobuyuki Shigetoh, Hiroshi Nakayama, Jinsei Miyazaki, Tadayasu Mitsumata, "Labelling colors for detecting cocaine or methamphetamine, method of preparing the same and detector for cocaine or methamphetamine." U.S. Patent US5571727, issued October, 1981.
US5571727

### General References

Siegel RK, Elsohly MA, Plowman T, Rury PM, Jones RT: Cocaine in herbal tea. JAMA. 1986 Jan 3;255(1):40. [
Article
]
Volkow ND, Wang GJ, Fischman MW, Foltin R, Fowler JS, Franceschi D, Franceschi M, Logan J, Gatley SJ, Wong C, Ding YS, Hitzemann R, Pappas N: Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 2000 Aug 11;67(12):1507-15. [
Article
]
Dimitrijevic N, Dzitoyeva S, Manev H: An automated assay of the behavioral effects of cocaine injections in adult Drosophila. J Neurosci Methods. 2004 Aug 30;137(2):181-4. [
Article
]
Uz T, Akhisaroglu M, Ahmed R, Manev H: The pineal gland is critical for circadian Period1 expression in the striatum and for circadian cocaine sensitization in mice. Neuropsychopharmacology. 2003 Dec;28(12):2117-23. [
Article
]
McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ: Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9377-81. Epub 2005 Jun 20. [
Article
]
FDA Approved Products: Numbrino (cocaine hydrochloride) nasal solution [
Link
]
FDA Approved Products: Goprelto (cocaine hydrochloride) nasal solution [
Link
]
DailyMed: Cocaine hydrochloride solution [
Link
]

### External Links

Human Metabolome Database
HMDB0015043
KEGG Drug
D00110
KEGG Compound
C01416
PubChem Compound
446220
PubChem Substance
46506326
ChemSpider
10194104
BindingDB
22418
RxNav
2653
ChEBI
27958
ChEMBL
CHEMBL370805
ZINC
ZINC000003875336
Therapeutic Targets Database
DAP000834
PharmGKB
PA449072
Guide to Pharmacology
GtP Drug Page
PDBe Ligand
COC
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
Wikipedia
Cocaine

### Human Metabolome Database

HMDB0015043

### KEGG Drug

D00110

### KEGG Compound

C01416

### PubChem Compound

446220

### PubChem Substance

46506326

### ChemSpider

10194104

### BindingDB

22418

### RxNav

2653

### ChEBI

27958

### ChEMBL

CHEMBL370805

### ZINC

ZINC000003875336

### Therapeutic Targets Database

DAP000834

### PharmGKB

PA449072

### Guide to Pharmacology

GtP Drug Page

### PDBe Ligand

COC

### RxList

RxList Drug Page

### Drugs.com

Drugs.com Drug Page

### Wikipedia

Cocaine

### PDB Entries

1i7z
/
1q72
/
2ajv
/
2pgz
/
4xp4
/
4xpb
/
8de3
/
9eo4

### MSDS

Download
(104 KB)

### Packagers

Cody Laboratories Inc.
Lannett Co. Inc.
Mallinckrodt Inc.
Roxane Labs

### Dosage Forms

Form
Route
Strength
Solution
Topical
100 mg/1mL
Solution
Topical
40 mg/1mL
Liquid
Topical
40 mg / mL
Liquid
Topical
100 mg / mL
Solution
Nasal
40 mg/1mL

### Prices

Unit description
Cost
Unit
Cocaine hydrochloride powder
68.44USD
g
Cocaine 10% solution
10.68USD
ml
Cocaine 4% solution
6.22USD
ml
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.

### State

Solid

### Experimental Properties

Property
Value
Source
melting point (°C)
98 °C
PhysProp
water solubility
1800 mg/L (at 22 °C)
YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP
2.30
HANSCH,C ET AL. (1995)
logS
-2.23
ADME Research, USCD
pKa
8.61 (at 15 °C)
MERCK INDEX (1996)

### Predicted Properties

Property
Value
Source
Water Solubility
5.03 mg/mL
ALOGPS
logP
1.97
ALOGPS
logP
2.28
Chemaxon
logS
-1.8
ALOGPS
pKa (Strongest Basic)
8.85
Chemaxon
Physiological Charge
1
Chemaxon
Hydrogen Acceptor Count
3
Chemaxon
Hydrogen Donor Count
0
Chemaxon
Polar Surface Area
55.84 Å
2
Chemaxon
Rotatable Bond Count
5
Chemaxon
Refractivity
81.16 m
3
·mol
-1
Chemaxon
Polarizability
32.02 Å
3
Chemaxon
Number of Rings
3
Chemaxon
Bioavailability
1
Chemaxon
Rule of Five
Yes
Chemaxon
Ghose Filter
Yes
Chemaxon
Veber's Rule
No
Chemaxon
MDDR-like Rule
No
Chemaxon

### Predicted ADMET Features

Property
Value
Probability
Human Intestinal Absorption
+
0.8644
Blood Brain Barrier
+
0.8805
Caco-2 permeable
+
0.7654
P-glycoprotein substrate
Substrate
0.5
P-glycoprotein inhibitor I
Inhibitor
0.8168
P-glycoprotein inhibitor II
Non-inhibitor
0.893
Renal organic cation transporter
Inhibitor
0.6182
CYP450 2C9 substrate
Non-substrate
0.7897
CYP450 2D6 substrate
Non-substrate
0.9116
CYP450 3A4 substrate
Substrate
0.6856
CYP450 1A2 substrate
Non-inhibitor
0.8627
CYP450 2C9 inhibitor
Non-inhibitor
0.9341
CYP450 2D6 inhibitor
Non-inhibitor
0.5614
CYP450 2C19 inhibitor
Non-inhibitor
0.9383
CYP450 3A4 inhibitor
Non-inhibitor
0.9237
CYP450 inhibitory promiscuity
Low CYP Inhibitory Promiscuity
0.9408
Ames test
Non AMES toxic
0.7437
Carcinogenicity
Non-carcinogens
0.9585
Biodegradation
Not ready biodegradable
0.5319
Rat acute toxicity
2.6387 LD50, mol/kg
Not applicable
hERG inhibition (predictor I)
Weak inhibitor
0.8463
hERG inhibition (predictor II)
Non-inhibitor
0.8042
ADMET data is predicted using
admetSAR
, a free tool for evaluating chemical ADMET properties. (
23092397
)

### Mass Spec (NIST)

Download
(2.96 KB)

### Spectra

Spectrum
Spectrum Type
Splash Key
Predicted GC-MS Spectrum - GC-MS
Predicted GC-MS
splash10-0a5a-9620000000-fd84236e0a4ca8f55456
GC-MS Spectrum - EI-B
GC-MS
splash10-001i-9200000000-5262d40bbcdec08759ab
GC-MS Spectrum - CI-B
GC-MS
splash10-0udi-0109000000-319d789d066a157a0966
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-0udi-0009000000-a2004e33ce1140fd0ed1
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-0f89-0908000000-b5abe87da56f09f21f65
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-001i-0900000000-ee9c7f3b491476f49e98
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-001i-0900000000-2dab4b98f61ec4ba2467
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-0fz9-0900000000-b3c61e257fbaf700b52b
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-001i-0900000000-3b1dc1a8c8390bfb6c3e
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-0udi-0009000000-0479d3211208134ed140
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-0ue9-0709000000-d19680d406708cbbc59b
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-001i-1900000000-5ac8f8a2719f70332b86
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-001i-3900000000-5ff2f6c28b5db03035be
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-053r-8900000000-e597f9f6f5014d501e62
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-0a5c-9500000000-0fcf099229f148719078
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-0udi-0009000000-ee11934dd1158606bb84
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-0ue9-0609000000-bd90cd1f98ce1845ba6b
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-001i-1900000000-9fc49ca16ab794b8c37d
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-001i-3900000000-cb0b593e7f379f7c6aef
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-053r-8900000000-2a88bad614aed29eac52
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-0a59-9500000000-c9713abdcf52a45d6ed2
LC-MS/MS Spectrum - LC-ESI-ITFT , positive
LC-MS/MS
splash10-001i-0900000000-c18cf276038cf1946f20
Predicted MS/MS Spectrum - 10V, Positive (Annotated)
Predicted LC-MS/MS
splash10-0udi-0429000000-98e2928cd21fb2234d5b
Predicted MS/MS Spectrum - 10V, Negative (Annotated)
Predicted LC-MS/MS
splash10-0fk9-0904000000-d5219fa2ebf7d3ed8fd3
Predicted MS/MS Spectrum - 20V, Positive (Annotated)
Predicted LC-MS/MS
splash10-0fk9-0982000000-9601082e7300a30880e8
Predicted MS/MS Spectrum - 20V, Negative (Annotated)
Predicted LC-MS/MS
splash10-00di-0900000000-985a213761c9d9403ae7
Predicted MS/MS Spectrum - 40V, Positive (Annotated)
Predicted LC-MS/MS
splash10-00di-3951000000-8fd09875f58791075b1f
Predicted MS/MS Spectrum - 40V, Negative (Annotated)
Predicted LC-MS/MS
splash10-00b9-9721000000-4d8187110632b8ce6a55
Predicted 1H NMR Spectrum
1D NMR
Not Applicable
Predicted 13C NMR Spectrum
1D NMR
Not Applicable

### Chromatographic Properties

Collision Cross Sections (CCS)
Adduct
CCS Value (Å
2
)
Source type
Source
[M-H]-
174.4089035
predicted
DarkChem Lite v0.1.0
[M-H]-
173.6360035
predicted
DarkChem Lite v0.1.0
[M-H]-
170.43347
predicted
DeepCCS 1.0 (2019)
[M+H]+
173.1699035
predicted
DarkChem Lite v0.1.0
[M+H]+
173.3030035
predicted
DarkChem Lite v0.1.0
[M+H]+
172.82906
predicted
DeepCCS 1.0 (2019)
[M+Na]+
173.5483035
predicted
DarkChem Lite v0.1.0
[M+Na]+
173.1510035
predicted
DarkChem Lite v0.1.0
[M+Na]+
179.20958
predicted
DeepCCS 1.0 (2019)

### Kind

Protein

### Organism

Humans

### Pharmacological action

No

### Actions

Inhibitor

### General Function

Mediates sodium- and chloride-dependent transport of dopamine (PubMed:10375632, PubMed:11093780, PubMed:1406597, PubMed:15505207, PubMed:19478460, PubMed:39112701, PubMed:39112703, PubMed:39112705, PubMed:8302271). Also mediates sodium- and chloride-dependent transport of norepinephrine (also known as noradrenaline) (By similarity). Regulator of light-dependent retinal hyaloid vessel regression, downstream of OPN5 signaling (By similarity)

### Specific Function

amine binding

### Gene Name

SLC6A3

### Uniprot ID

Q01959

### Uniprot Name

Sodium-dependent dopamine transporter

### Molecular Weight

68494.255 Da

### Curator comments

Data suggest that cocaine is a weak inhibitor.

`,
  "drugusersbible": `# Cocaine
*Source: Drug Users Bible by Dominic Milton Trott*

*Section 2.3.13 - CHEMSCAPE: A Chemical Journey*

## Quick Reference
- **Common Nomenclature:** Benzoylmethylecgonine
- **Street & Reference Names:** Coke; Crack; Blow; Snow; Nose Candy
- **Reference Dosage:** Light 20mg+; Common 50mg+; Strong 100mg+;
- **Anticipated: Onset / Duration:** 2 Minutes / 90 Minutes
- **Maximum Dose Experienced:** 200 mg *[See also 4.10 Supplementary Notes]
- **Form:** Powder
- **RoA:** Oral / Smoked / Insufflated
- **Source / Jurisdiction:** Dealer / Overseas

## Subjective Experience

One of the most famed of drugs, cocaine is sourced from the coca plant, and is widely
known for its short term high and addiction potential.

In a previous life, in what now seems eons ago (the 1990s), I experienced it both
orally and by smoking (inhaling its vapours). This was the folly of youth and high risk
stupidity, or at least it was on the first occasion.

I found myself on West 42nd Street in Midtown Manhattan where I was offered the
substance by a street vendor. It came in the form of a paste/fluid, within a small
plastic transparent tube. Having had far too much to drink, I swallowed it. This was
naïve, foolish and embarrassing.

The reaction was minimal, certainly during the first few hours. I have since learned
that the absorption rate via oral consumption is only about 30%, which may actually
have been a positive, given the lack of common sense in such a rash scenario. The
alcohol will also have played a part in disguising or suppressing the effect.

The only notable aspect of this mess came the next day, when my head should have
been throbbing with an alcohol hangover. It wasn't. Indeed, I felt remarkably
functional and healthy.

What I did in mixing was dangerous, but fortunately, I drank plenty of water before
sleeping. This may have helped, but was insufficient to explain my luck regarding the
missing headache.

Subsequent research did shed some light upon this: cocaine can indeed disguise and
mitigate the pain of excessive alcohol consumption. In fact, it is commonly stated on
the Internet that Coca Cola originally contained cocaine, and was used widely as a
hangover cure (orally, obviously). I suspect, therefore, that rather than purchasing a
drug induced high, I actually bought my way out of a day's suffering whilst on the
tourist trail.

The second cocaine experience occurred in Amsterdam. On one particular evening I
found myself in what can best be described as a drug commune, or perhaps in
modern lingo a crack house, in an old city centre building. Cocaine and heroin were
being shared in tiny white bags (reminiscent of the blue Salt 'n' Shake salt packets in
a bag of crisps).

The contents of these were placed in a metal bowl, heated and smoked/inhaled.
Being careful to take only the cocaine, I engaged. Retrospectively, I now understand
that this will have been the free base form of cocaine, commonly known as crack.

This experience was a little vague, but by and large, I recall an uplifted feeling and
perhaps a short high, albeit not mind blowing in nature. Certainly I wasn't in the
realms of wanting more, either then or since.

Zooming forwards to my relatively sane and sensible modern era of risk management
and harm mitigation, I finally tested cocaine via its most common RoA: insufflation.

The vendor promised that my 100mg (actually 75mg) was over 83% "Peruvian
Flake". The substance itself was easy enough to crush into lines, even though its
constitution wasn't brittle (it was flaky). I proceeded to sample:

\`\`\`
T+0:00 Two lines of approximately 25mg are snorted. There is no real pain,
but mild numbing, so I suspect it is cut with lidocaine or similar. [4:27pm]
\`\`\`
\`\`\`
T+0:05 Perhaps it is due to exposure to a reasonably high dose of
amphetamine three weeks ago, or some other cross tolerance, but the uplift at
this point is minimal.
\`\`\`
\`\`\`
I feel a gentle stimulation, but given no intake of cocaine for over 20 years, I
am underwhelmed. Yes, I can feel something coming on, but there is no rush
or euphoria. Onset is described as 2-20 minutes, so I will give it a few more
minutes before pushing it with the other 25mg.
\`\`\`

\`\`\`
T+0.10 I snort the last 25mg, so if the purity claimed by the dealer is
anywhere near to being accurate, I should be well into the territory of a
common dose.
\`\`\`
\`\`\`
T+0.15 This is more like it. Whilst not feeling mind blown, I do feel elevated. I
feel warm, and with a familiar sort of gently elevated headspace, inclusive of a
mild visual clarity and a calmness. There is a little horn if I think about it. My
pupils appear to be normal when I check in the mirror.
\`\`\`
\`\`\`
T+0:20 Mentally, I feel that I am in a place from which I could happily
socialize, feel comfortable about it, and have a good time. However, staying
indoors and doing nothing in particular still provides a mild sense of euphoria
and pleasure.
\`\`\`
\`\`\`
T+0:35 There is no change at this point. I am certainly high, although with a
larger dose I would probably be even more exhilarated, with more horn, and
so forth. The big question from here is how long will this last?
\`\`\`
\`\`\`
My experiences with other stimulants have frequently lasted for hours, often
too many hours. If this is significantly shorter, as is suggested, I can
understand its enormous popularity, subject to the nature of the comedown.
\`\`\`
\`\`\`
T+0:50 I remain in a very nice place. A heady stim-like buzz pervades, but it is
light enough to enable unimpaired functionality.
\`\`\`
\`\`\`
At the back of my mind is the thought that even though I find it to be rather
pleasing, the experience would be even better for anyone new to
psychoactives, or even to myself when I was inexperienced and less inured to
the world of the drug headspace.
\`\`\`
\`\`\`
T+1:10 I am coming-down now, fairly gently so far. I am still experiencing an
elevated mood, but less so, and the head stim has almost dissipated.
\`\`\`
\`\`\`
This has been a pleasant experience. It's all about the residuals from here.
\`\`\`
The rest of the day passed quite normally and the night's sleep was fine. In the
morning I felt no indication of hangover, possibly due to the sensible dose I was
restricted to.

On the following day, perhaps because of this lack of negative payload, the thought
crossed my mind that I would quite like to snort another line or two. This is not the
best sign, as it flashes a big red light.

Note that on a subsequent test, with a dose of 200mg over a number of hours, the
aftermath was not as kind. However, it was still significantly gentler than that of
many other stimulants. The slippery slope to addiction does appear to be less obvious
than for most other drugs in this class. Be careful with respect to this: very careful.

STRAIGHT OUT OF THE BAGGIE
Other than the crack I inadvertently sampled in my early 20s, my cocaine usually
came in either powder or brick form (although it was occasionally offered as
Peruvian flake, as per the earlier photographs).

\`\`\`
Columbian Washed versus Bolivian Brick
\`\`\`
HOT PLATING
This is a common practice which is used to get more bang for your buck. It consists
of putting a glass or ceramic plate into a microwave, heating it until it is hot (usually
about a minute), and then crushing the cocaine on to it to create a dryer finer
powder.

COCAINE NOSE
It’s hardly a secret that prolonged use of cocaine can cause (considerable) damage to
your nose, nostrils and sinuses. In this respect I would direct you to the segment on
nasal care in the first section of this book. I would add to this that you should only
snort off a clean surface and only with the use of a clean snorter (and certainly not
with a pound note or dollar bill).

Sharing the snorter (or whatever is used) is also a serious no-no, as it can
significantly increase the risk of infection. Again, don’t suspend basic hygiene.

Finally, one step I personally take but which I don’t often see mentioned (perhaps it’s
too obvious) is to snort lines using alternate nostrils. Another is to blow your nose
properly and fully at the end of the session.

SOMETHING ABOUT YOUR COCAINE
One rainy afternoon I started to look at the contents of the cocaine samples
submitted to a well known UK lab. Of focus was the issue of what cocaine is
commonly bulked or cut with (not including other mainstream drugs).

162 samples were submitted as cocaine from September 2020 to April 2021. From
these 50 (31%) were listed solely as cocaine, with no other recorded content. I broke
the rest down into two sets: those which returned a single addition, and those which
returned multiple additions. The resultant figures were as follows:

\`\`\`
Single Addition (64 samples in total):
21 (13.0%) = Benzoylecgonine
17 (10.5%) = Levamisole
10 (6.2%) = Norcocaine
7 (4.3%) = Benzocaine
6 (3.7%) = Phenacetin
1 (0.6%) = Paracetamol
1 (0.6%) = Metformin
1 (0.6%) = Lidocaine
\`\`\`
\`\`\`
Multiple Additions (48 samples in total)
10 (6.2%) = Levamisole + Benzoylecgonine
7 (4.3%) = Levamisole + Norcocaine
5 (3.1%) = Levamisole + Benzoylecgonine + Norcocaine
4 (2.5%) = Benzoylecgonine + Norcocaine
3 (1.9%) = Benzoylecgonine + Ecgonine methyl ester
2 (1.2%) = Benzocaine + Norcocaine
2 (1.2%) = Phenacetin + Benzocaine
2 (1.2%) = Phenacetin + Norcocaine
2 (1.2%) = Benzoylecgonine + Norcocaine + Ecgonine methyl ester
1 (0.6%) = Levamisole + Phenacetin
1 (0.6%) = Phenacetin + Norcocaine + Benzocaine
1 (0.6%) = Tropacocaine + Norcocaine + Benzoylecgonine + Ecgonine methyl ester
1 (0.6%) = Levamisole + Norcocaine + Benzocaine
1 (0.6%) = Levamisole + Norcocaine + Benzoylecgonine + Tropacocaine
1 (0.6%) = Benzocaine + Ecgonine methyl ester
1 (0.6%) = Phenacetin + Ecgonine methyl ester + Benzoylecgonine + Caffeine + Benzocaine
1 (0.6%) = Levamisole + Metformin + Norcocaine + Benzoylecgonine
1 (0.6%) = Levamisole + Benzoylecgonine + Norcocaine + Ecgonine methyl ester
1 (0.6%) = Benzoylecgonine + Procaine + Norcocaine + Ecgonine methyl ester
1 (0.6%) = Levamisole + Benzoylecgonine + Phenacetin + Ecgonine methyl ester
\`\`\`
It should be noted that not all of these are bulking or cutting agents: some simply
result from degradation or production issues. Referring to them as additions or
additives is probably not the best terminology.

What didn't surprise me though was that levamisole ranked so highly (present in
28% of all samples); although this wasn't as high as I feared. It is widely known that
this is used to treat parasitic worm infections, and that it is a very bad idea to snort
large volumes. I was also surprised at the low ranking of lidocaine, as I expected it to
be the primary anaesthetic/agent. Perhaps I am showing my age again, which also
leads me to wonder what happened to procaine.

\`\`\`
Cocaine is cited frequently in lists of drug related celebrity deaths (see Section
4.3.5). I ran across this plaque outside the Hotel Prins Hendrik in Amsterdam,
from which jazz legend Chet Baker accidentally fell to his death with both
cocaine and heroin present in his system.
\`\`\`
`,
  "protestkit": `{
  "url": "https://psychonautwiki.org/wiki/Cocaine",
  "experiencesUrl": "https://www.erowid.org/experiences/subs/exp_Cocaine.shtml",
  "name": "Cocaine",
  "aliases": [
    "blow",
    "chari",
    "coca",
    "coke",
    "crack",
    "girl",
    "nose candy",
    "snow",
    "white"
  ],
  "aliasesStr": "blow,chari,coca,coke,crack,girl,nose candy,snow,white",
  "summary": "A highly popular, short acting CNS stimulant that works by blocking the reuptake of dopamine, serotonin, and norepinephrine. It is known to increase euphoria, confidence, sex-drive, focus, body temperature, and heart rate. Cocaine can cause severe vasoconstriction and is known to be cardiotoxic and have a high potential for compulsive redosing and addiction.",
  "reagents": null,
  "classes": {
    "chemical": [
      "Substituted tropanes"
    ],
    "psychoactive": [
      "Stimulants"
    ]
  },
  "toxicity": [
    "individuals have died from as little as 30 mg applied to mucous membranes, whereas addicts may tolerate up to 5 grams daily"
  ],
  "addictionPotential": "highly addictive with a high potential for abuse",
  "tolerance": {
    "full": "develops with prolonged and repeated use",
    "half": "3 - 7 days",
    "zero": "1 - 2 weeks"
  },
  "crossTolerances": [
    "dopamine",
    "stimulant"
  ],
  "roas": [
    {
      "name": "Smoked",
      "dosage": null,
      "duration": [
        {
          "name": "Onset",
          "value": "0.05 - 0.08 minutes"
        },
        {
          "name": "Come up",
          "value": "1.0 - 2.0 minutes"
        },
        {
          "name": "Peak",
          "value": "2.0 - 10.0 minutes"
        },
        {
          "name": "Offset",
          "value": "1.0 - 5.0 minutes"
        },
        {
          "name": "Total",
          "value": "5.0 - 15.0 minutes"
        }
      ]
    },
    {
      "name": "Insufflated",
      "dosage": [
        {
          "name": "Threshold",
          "value": "5 mg"
        },
        {
          "name": "Light",
          "value": "10 - 30 mg"
        },
        {
          "name": "Common",
          "value": "30 - 60 mg"
        },
        {
          "name": "Strong",
          "value": "60 - 90 mg"
        },
        {
          "name": "Heavy",
          "value": "90 mg +"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "1.0 - 10.0 minutes"
        },
        {
          "name": "Come up",
          "value": "5.0 - 15.0 minutes"
        },
        {
          "name": "Peak",
          "value": "15.0 - 30.0 minutes"
        },
        {
          "name": "Offset",
          "value": "10.0 - 30.0 minutes"
        },
        {
          "name": "Total",
          "value": "10.0 - 90.0 minutes"
        }
      ],
      "bioavailability": "60-80%"
    }
  ],
  "interactions": [
    {
      "name": "2C-T-x",
      "status": "Unsafe"
    },
    {
      "name": "2C-x",
      "status": "Caution"
    },
    {
      "name": "5-MeO-xxT",
      "status": "Unsafe"
    },
    {
      "name": "Alcohol",
      "status": "Unsafe"
    },
    {
      "name": "Amphetamines",
      "status": "Caution"
    },
    {
      "name": "Benzos",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Caffeine",
      "status": "Caution"
    },
    {
      "name": "Cannabis",
      "status": "Caution"
    },
    {
      "name": "DMT",
      "status": "Caution"
    },
    {
      "name": "DOx",
      "status": "Unsafe"
    },
    {
      "name": "DXM",
      "status": "Unsafe"
    },
    {
      "name": "GHB/GBL",
      "status": "Caution"
    },
    {
      "name": "Gabapentinoids",
      "status": "Caution"
    },
    {
      "name": "Ketamine",
      "status": "Caution"
    },
    {
      "name": "LSD",
      "status": "Caution"
    },
    {
      "name": "MAOIs",
      "status": "Dangerous"
    },
    {
      "name": "MDMA",
      "status": "Caution"
    },
    {
      "name": "MMC class",
      "status": "Caution"
    },
    {
      "name": "MXE",
      "status": "Caution"
    },
    {
      "name": "Mescaline",
      "status": "Caution"
    },
    {
      "name": "Mushrooms",
      "status": "Caution"
    },
    {
      "name": "NBOMes",
      "status": "Unsafe"
    },
    {
      "name": "Nitrous",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Opioids",
      "status": "Dangerous"
    },
    {
      "name": "PDA5",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PVP class",
      "status": "Unsafe"
    },
    {
      "name": "Poppers",
      "status": "Caution"
    },
    {
      "name": "SSRIs",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Tramadol",
      "status": "Dangerous"
    }
  ],
  "effects": "Elevated mood. Increase in irritability, hyper-inflated ego, euphoria, stimulation, raised heartrate, numbing effects depending on ROA, nausea (particularly at high doses)",
  "categorized_effects": {
    "Physical effects": [
      "vasoconstriction",
      "temporary erectile dysfunction",
      "increased heart rate",
      "increased blood pressure",
      "teeth grinding",
      "stimulation",
      "raised heartrate",
      "numbing effects depending on ROA",
      "nausea (particularly at high doses)"
    ],
    "Mental effects": [
      "Elevated mood. Increase in irritability",
      "hyper-inflated ego",
      "euphoria"
    ],
    "Sensory effects": [],
    "Uncategorized effects": []
  }
}`,
  "saferparty": `# Cocaine
*Source: [SaferParty](https://saferparty.ch) - Drug Checking Service (Switzerland)*

## Effects
The increased release and additional reuptake inhibition of the body's own neurotransmitters dopamine and noradrenaline lead to the suppression of tiredness, hunger and thirst, euphoria, feelings of increased performance, greatly increased self-confidence, urge to move, restlessness, talkativeness, elimination of inhibitions and fears, suppressed sense of pain, as well as increased willingness to take risks.

Coca leaves are known as "Mate de Coca" or dried leaves. These dried leaves contain about 0.5 to 2.5 % alkaloids, of which up to three quarters consist of cocaine. The leaves are chewed or drunk as tea. However, a psychoactive effect only occurs when they are taken in combination with a basic substance (e.g. lime or plant ash). This combination activates a hydrolysis, resulting in the alkaloid ecgonine. Ecgonine can be absorbed by the body and a slightly stimulating effect sets in. In contrast to cocaine, ecgonine has no dependence potential. If coca leaves are chewed without alkaline additives, they only have a numbing effect on the tongue. Coca leaves are used in South America mainly for medicinal purposes, e.g. to combat nausea or altitude sickness.

## Risks

### Short-term Risks
Sleep disturbances, irritability, aggressiveness, exaggerated egocentrism up to "megalomania", decrease in critical and judgemental ability, anxiety and delusions, depression, memory/concentration disorders, shortness of breath, hyperactivity, nervous twitching, muscle cramps and tremors, high stress on the cardiovascular system due to constriction of the blood vessels, increase in heart rate, increased blood pressure and hypertensive crises. In extreme cases, overdose can lead to a heart attack or stroke.
When the effect wears off: exhaustion, depressive moods, irritability, feelings of anxiety and a strong urge to take the drug again ("craving").

### Long-term Risks
Chronic use: psychological dependence. "Craving" (irresistible and uncontrollable desire to consume) can be triggered quickly by so-called trigger effects (situations, memories, people, etc., which are associated with consumption). Other long-term risks are anxiety disorders, personality changes such as reduced empathy, emotional coldness, exaggerated mistrust, depression, mental disorders with paranoid delusions and hallucinations, alteration of thought processes, permanent disturbances of short-term memory and intellectual abilities. Nerve damage, nervous twitching, seizures, alteration of movement patterns, damage to: Heart, liver, kidneys, lungs, skin, blood vessels and teeth. General weakening of the immune system, in extreme cases with necrosis (death of skin cells), liver damage due to the breakdown of toxins and the risk of kidney damage due to extender.
Chronic inflammation and damage to the nasal mucous membranes and nasal septum, which is difficult to heal. When smoking freebase and crack, damage to the lungs and respiratory tract is possible due to the deposition of combustion residues (ash residues). When injecting or smoking (freebase), the phenomenon of "dermatozoan madness" (the idea that there are worms or insects under the skin, perception of a tingling sensation under the skin) is known. Colloquially also called "cocaine worms/bugs"). This delusion leads to excessive scratching of the arms and/or legs, up to open injuries, which can lead to abscesses if hygiene is poor.

## Safer Use
- Attention, very high risk of psychological dependence! Take breaks from using, especially if it is difficult for you.
- Keep the dosage low and avoid frequent refilling!
- Drink enough soft drinks and take breaks in the fresh air.
- Eat healthy before and after consumption and do not consume on an empty stomach.
- Follow the safer sniffing and safer sex rules.
- Snorting is the lowest-risk form of use. Smoking crack and freebase as well as injecting increase the risks (no syringe exchange!).
- People with pre-existing cardiovascular conditions, asthma, liver disease, hyperthyroidism and pregnant women should not use cocaine.
- Do not combine cocaine with other stimulants or drugs that increase blood pressure.
- Do not use cocaine if you have used ecstasy; this will cancel out the ecstasy effect.
- Do not mix cocaine with alcohol; the mixture makes you aggressive and you risk alcohol poisoning.

## Adulterants & Extenders

### Common Adulterants

**Dimethylterephthalate**
Dimethyl terephthalate is a basic material for the technical production of polyesters, for example polyethylene terephthalate (PET) or polybutylene terephthalate (PBT). It is also used in the production of polyester resins for films, lacquers and adhesives and of 1,4-dimethylolcyclohexane. The abbreviation for dimethyl terephthalate is DMT; it is possible that there is confusion here with dimethyl triytamine, whose abbreviation is also DMT.

**Buflomedil**
Buflomedil is a drug for the supportive treatment of peripheral arterial occlusive disease (PAD). This disease causes pain in the legs, for example when walking, because the arteries are narrowed by deposits in their lumen and therefore less blood with nutrients reaches the muscle tissue in the legs. The drug promotes blood flow in medium and small arterial blood vessels. It is an antagonist at α-adrenoreceptors.

**Hydroxyzine**
The effects are based, among other things, on antagonism at histamine H1 receptors and anticholinergic properties. The drug hydroxyzine acts at several sites in the body: It influences different messenger systems in the brain and the rest of the body. As a result, it has a calming effect, relieves tension and anxiety, soothes nausea and relieves itching. Hydroxyzine has a strong calming effect and promotes sleeping through the night. It is particularly suitable for night-time relief of severe itching in allergies and neurodermatitis.

**Lidocaine**
Lidocaine is an amide-type local anaesthetic that is also used as a class Ib antiarrhythmic.

**Piracetam**
Piracetam is a cyclic derivative (γ-lactam) of γ-aminobutyric acid (GABA) and a drug from the group of anti-dementia drugs (nootropics).

**Procaine**
Procaine is now rarely used for local anaesthesia, as more effective substances, such as lidocaine, are available for this purpose.

**Levamisole**
S)-6-phenyl-2,3,5,6-tetrahydroimidazo(2,1-b)(1,3)thiazole. Levamisole was originally used as an agent against threadworms (anthelmintic), but has not been used in human medicine since 2004 because of undesirable drug effects.

**Diltiazem**
Diltiazem is a calcium channel blocker that has a vasodilatory effect and delays conduction in the AV node of the heart.
Possible side effects: Swelling of the lymph nodes, vomiting, heartburn, diarrhoea, feeling of weakness, oedema.

**Tetracaine**
Tetracaine is used as a surface anaesthetic of mucous membranes - for example for minor procedures in the mouth or nose.

**Phenacetin**
Phenacetin is an active substance from the group of analgesics with analgesic and antipyretic effects. A large proportion of the active substance is converted into paracetamol in the body. Due to its toxicity to the kidneys and the risk of carcinogenesis in the urinary tract, phenacetin is no longer on the market.
`,
  "tripsit-factsheets": `# Cocaine
*Source: TripSit Factsheets (tripsit.me)*

## Summary

A highly popular, short-acting CNS stimulant that works by blocking the reuptake of dopamine, serotonin, and norepinephrine. It is known to increase euphoria, confidence, sex-drive, focus, body temperature, and heart rate. Cocaine can cause severe vasoconstriction and is known to be cardiotoxic and have a high potential for compulsive redosing and addiction.

## Classification
- **Categories:** stimulant, habit-forming, common
- **Also known as:** coke

## Dosage

### Insufflated
- **Common:** 50-100mg
- **Heavy:** 150mg+
- **Light:** 20-50mg
- **Strong:** 100-150mg

*Note: Rapid onset. Depending on purity, dosage will vary*

## Duration
- **Duration:** 1-1.5 hours
- **After Effects:** 1-4 hours

## Effects
- Elevated mood
- Increase in irritability
- hyper-inflated ego
- euphoria
- stimulation
- raised heartrate
- numbing effects depending on ROA
- nausea (particularly at high doses)

## Interactions

### ⛔ Dangerous
- **amt**
- **maois**: This combination is poorly explored
- **opioids**: Stimulants increase respiration rate allowing for a higher dose of opiates than normal. If the stimulant wears off first then the opiate may overcome the individual and cause respiratory arrest.
- **tramadol**: Tramadol and stimulants both increase the risk of seizures.

### ⚠️ Unsafe
- **2c-t-x**: Cocaine and 2c-t-x both provide considerable stimulation. When combined they can result in severe vasoconstriction, tachycardia, hypertension, and in extreme cases heart failure.
- **5-meo-xxt**: The anxiogenic and focusing effects of stimulants increase the chance of unpleasant thought loops. The combination is generally unnecessary because of the stimulating effects of psychedelics. 
- **alcohol**: Cocaine can decrease some of the intoxicating effects of alcohol, causing some people to drink more than they otherwise would, which leads to greater behavioral and physical health risks. There is also some debate about cocaethylene, a metabolite produced when combining alcohol and cocaine, with some researchers positing that it is more cardiotoxic than cocaine on its own. Use moderation when combining these substances.
- **dextromethorphan**: Both substances raise heart rate, in extreme cases, panic attacks caused by these drugs have led to more serious heart issues
- **dox**: The combined stimulating effects of the two can lead to an uncomfortable body-load, while the focusing effects of cocaine can easily lead to thought loops. Coming down from cocaine while the DOx is still active can be quite anxiogenic
- **nbomes**: Cocaine and NBOMes both provide considerable stimulation. When combined they can result in severe vasoconstriction, tachycardia, hypertension, and in extreme cases heart failure.
- **pcp**: This combination can easily lead to hypermanic states
- **pregabalin**: There is a significant risk of seizures from this combination. Stimulants increase respiration rate, allowing for a higher dose of sedatives than normal. If cocaine wears off first, recreational dosages of pregabalin may overcome the individual and cause respiratory arrest. Both substances at recreational dosages strain the heart and may lead to further dangerous heart complications. The combination has a greater risk of methemoglobinemia when higher dosages are combined.

### ⚡ Caution
- **2c-x**: The anxiogenic and focusing effects of stimulants increase the chance of unpleasant thought loops. The combination is generally unnecessary because of the stimulating effects of psychedelics. Combination of the stimulating effects may be uncomfortable.
- **amphetamines**: This combination of stimulants will increase strain on the heart. It is not generally worth it as cocaine has a mild blocking effect on dopamine releasers like amphetamine
- **caffeine**: Both stimulants, risk of tachycardia, hypertension, and in extreme cases heart failure.
- **cannabis**: Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
- **diphenhydramine**: Stimulants increase respiration rate allowing for a higher dose of sedatives than normal. If cocaine wears off first, recreational dosages of DPH may overcome the individual and cause respiratory arrest. Both substances at recreational dosages strain the heart and may lead to further dangerous heart complications. When taken together, both substances can potentially be more reinforcing and have greater risk of methemoglobinemia when higher dosages of DPH are combined with cocaine.
- **dmt**: Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
- **ghb/gbl**: Stimulants increase respiration rate allowing for a higher dose of sedatives than normal. If the stimulant wears off first the opiate may overcome the individual and cause respiratory arrest. Likewise the ghb/gbl can wear off and leave a dangerous concentration of cocaine behind
- **ketamine**: No unexpected interactions, though likely to increase blood pressure but not an issue with sensible doses. Moving around on high doses of this combination may be ill advised due to risk of physical injury.
- **lsd**: Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
- **mdma**: Cocaine blocks some of the desirable effects of MDMA while increasing the risk of heart attack.
- **mescaline**: The focus and anxiety caused by stimulants is magnified by psychedelics and results in an increased risk of thought loops
- **mushrooms**: Stimulants increase anxiety levels and the risk of thought loops which can lead to negative experiences
- **mxe**: Stimulants taken with MXE can lead to hypermanic states much more easily, especially if sleep is avoided.

### ↓ Low Risk & Decrease
- **benzodiazepines**
- **lithium**: Lithium may inhibit some of the recreational effects of cocaine.

### ✓ Low Risk & Synergy
- **nitrous**

### ✓ Low Risk & No Synergy
- **ssris**: May reduce each others' effectiveness. Cocaine can reduce mental stability and therefore exacerbate conditions which SSRIs are used to treat.

## External Links
- [experiences](https://www.erowid.org/experiences/subs/exp_Cocaine.shtml)
`,
  "wikipedia": `# Cocaine
*Source: https://en.wikipedia.org/wiki/Cocaine*

Cocaine is a tropane alkaloid and stimulant of the central nervous system, derived primarily from the leaves of two coca species native to South America: Erythroxylum coca and E. novogranatense The leaves are processed into cocaine paste, a crude mixture of coca alkaloids, from which cocaine base is isolated and then converted to cocaine hydrochloride. Although total synthesis is possible, it is complex and not used for production. Historically, cocaine was a standard topical medication used as a local anesthetic with intrinsic vasoconstrictor properties. However, its high abuse potential, adverse effects, and cost have limited its medical use and led to its replacement by alternative medicines.
Street cocaine is commonly snorted, injected, or smoked as crack cocaine; its effects last up to 90 minutes depending on the route of administration. Pharmacologically, cocaine acts as a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI), producing reinforcing effects such as euphoria, increased alertness, concentration, libido, and reduced fatigue and appetite.
Cocaine has numerous adverse effects. Acute use can cause vasoconstriction, tachycardia, hypertension, hyperthermia, or seizures, while overdose may lead to stroke, heart attack, or sudden cardiac death. It also produces a spectrum of psychiatric symptoms, including agitation, paranoia, anxiety, irritability, psychosis, hallucinations, delusions, violence, and suicidal or homicidal thinking. Prenatal exposure poses risks to fetal development. Chronic use may result in cocaine dependence, withdrawal symptoms, neurotoxicity, and nasal damage, including cocaine-induced midline destructive lesions.
Coca cultivation and initial processing occur primarily in Latin America, especially in the Andes regions of Bolivia, Peru, and Colombia. Cultivation is expanding into Central America, including Honduras, Guatemala, and Belize. Violence linked to the cocaine trade continues to affect Latin America and the Caribbean and is expanding into Western Europe, Asia, and Africa as transnational organized crime groups compete globally. Cocaine remains the world's fastest-growing illicit drug market.
Coca chewing dates back at least 8,000 years in South America. Large-scale cultivation occurred in Taiwan and Java prior to World War II. The cocaine boom—a sharp rise in illegal production and trade—began in the late 1970s and peaked in the 1980s. Cocaine is regulated under international drug control conventions, though its legal status varies nationally: several countries have decriminalized possession of small quantities.

## Uses

Coca leaves have been used by Andean civilizations since ancient times. In ancient Wari culture, Inca culture, and through modern successor indigenous cultures of the Andes Mountains, coca leaves are chewed, taken orally in the form of a tea, or alternatively, prepared in a sachet wrapped around alkaline burnt ashes, and held in the mouth against the inner cheek; it has traditionally been used as an anorectic and to combat the effects of cold and altitude sickness, although its actual effectiveness has never been systematically studied.
Globally, in 2019, cocaine was used by an estimated 20 million people (0.4% of adults aged 15 to 64 years). The highest prevalence of cocaine use was in Australia and New Zealand (2.1%), followed by North America (2.1%), Western and Central Europe (1.4%), and South and Central America (1.0%). Since 1961, the Single Convention on Narcotic Drugs has required countries to make recreational use of cocaine a crime. In the United States, cocaine is regulated as a Schedule II drug under the Controlled Substances Act, meaning that it has a high potential for abuse but has an accepted medical use. While rarely used medically today, its accepted uses include serving as a topical local anesthetic for the upper respiratory tract and as an antihemorrhagic agent to stop bleeding in the mouth, throat, and nasal cavities.

### Traditional medicine

#### Coca leaves

It is legal for people to use coca leaves in the Andean Community, such as Peru and Bolivia, and Argentina, where they are chewed, consumed in the form of tea, or are sometimes incorporated into food products. Coca leaves are typically mixed with an alkaline substance (such as slaked lime) and chewed into a wad that is retained in the buccal pouch (mouth between gum and cheek, much the same as chewing tobacco is chewed) and sucked of its juices. The juices are absorbed slowly by the mucous membrane of the inner cheek and by the gastrointestinal tract when swallowed.

##### Coca tea

Coca herbal infusion (also referred to as coca tea) is used in coca-leaf producing countries much as any herbal medicinal infusion would elsewhere in the world. The free and legal commercialization of dried coca leaves under the form of filtration bags to be used as "coca tea" has been actively promoted by the governments of Peru and Bolivia for many years as a drink having medicinal powers. In Peru, the National Coca Company, a state-run corporation, sells cocaine-infused teas and other medicinal products and also exports leaves to the U.S. for medicinal use. The effects of drinking coca tea are mild stimulation and mood lift.
In 1986 an article in the Journal of the American Medical Association revealed that U.S. health food stores were selling dried coca leaves to be prepared as an infusion as "Health Inca Tea". While the packaging claimed it had been "decocainized", no such process had actually taken place. The article stated that drinking two cups of the tea per day gave a mild stimulation, increased heart rate, and mood elevation, and the tea was essentially harmless.

##### Ypadu

Ypadú or ypadu (also known as mambé) is an unrefined, unconcentrated powder made from toasted coca leaves and the ash of various other plants. It is traditionally prepared and consumed by indigenous tribes in the Northwest Amazon. Like coca teas consumed in Peru to adapt to sickness induced by high elevation, it has a long ethnobotanical history and cultural associations.

### Medical

Karl Koller's groundbreaking discovery of cocaine as a local anesthetic is regarded as the second most significant advance in the history of anesthesia. Although cocaine was once widely preferred for topical anesthesia, the search for replacement agents intensified due to rising costs, strict regulations, and its habit-forming potential. Cocaine is not included on the WHO Model List of Essential Medicines; the list formally excludes "cocaine and its combinations" as therapeutic alternatives to ophthalmological preparations.
Today, the US Drug Enforcement Administration (DEA) classifies cocaine as a Schedule II drug, recognizing its high potential for abuse but still permitting its limited use for medical purposes. However, current pharmacoepidemiological trends suggest that cocaine may soon reach the point where, in practical terms, it is no longer used medically in health care as a Schedule II substance. This report may prompt some states (such as North Dakota) and institutions to reconsider whether further efforts to identify alternative agents are needed. As physician boards—but not pharmacy boards—continue to assess knowledge of licit cocaine, attention may shift toward drugs with more contemporary medical use.
Cocaine is rarely prescribed in modern medicine due to its high potential for abuse and significant risk of adverse effects; its use is now almost exclusively limited to health facilities for specific diagnostic procedures or surgeries.

#### Topical

Cocaine is used in medical practice as a topical medication. Because it is not absorbed into the bloodstream in significant amounts when used this way, topical application does not produce the psychoactive effects associated with recreational cocaine use.

##### Topical anesthetic

Cocaine is sometimes used in otorhinolaryngology as a topical anesthetic and vasoconstrictor to help control pain and bleeding during surgery of the nose, mouth, throat, or lacrimal duct. It is also used for topical airway anaesthesia for procedures such as awake fibreoptic bronchoscopy or intubation. Although some absorption and systemic effects may occur, the use of cocaine as a topical anesthetic and vasoconstrictor is generally safe, rarely causing cardiovascular toxicity, glaucoma, and pupil dilation. Occasionally, cocaine is mixed with adrenaline and sodium bicarbonate and used topically for surgery, a formulation called Moffett's solution. It is occasionally used in surgeries involving the pharynx or nasopharynx to reduce pain, bleeding, and vocal cord spasm.
Nasal solution cocaine hydrochloride (Goprelto), an ester used for intranasal application, was approved for medical use in the United States in December 2017, and is indicated for the introduction of topical anesthesia of the mucous membranes for diagnostic procedures and surgeries on or through the nasal cavities of adults. Cocaine hydrochloride (Numbrino) was approved for medical use in the United States in January 2020. Headache and epistaxis are the most frequently reported adverse reactions with Goprelto, while hypertension and tachycardia-including sinus tachycardia-are most common with Numbrino.

##### Ophthalmological use

Cocaine eye drops have traditionally been used by neurologists when examining people suspected of having Horner syndrome. In Horner syndrome, sympathetic innervation to the eye is blocked. In a healthy eye, cocaine stimulates the sympathetic nervous system (SNS) by inhibiting norepinephrine reuptake, causing the pupil to dilate. In patients with Horner syndrome, sympathetic innervation to the eye is disrupted, so the affected pupil does not dilate in response to cocaine and remains constricted, or dilates to a lesser extent than the unaffected eye, which also receives the eye drop test. If both eyes dilate equally, the patient does not have Horner syndrome.
However, apraclonidine has largely replaced cocaine as the first-line pharmacologic agent for the diagnosis of Horner syndrome in routine clinical practice.

### Recreational

Recreational cocaine is typically not taken by mouth due to its poor bioavailability, instead it is usually snorted or injected. Cocaine hydrochloride can also be chemically converted into its free base form, crack cocaine, which can be vaporized.
Cocaine is a central nervous system stimulant. Its effects can last from 15 minutes to an hour. The duration of cocaine's effects depends on the amount taken and the route of administration. Cocaine can be in the form of fine white powder and has a bitter taste. Crack cocaine is a smokeable form of cocaine made into small "rocks" by processing cocaine with sodium bicarbonate (baking soda) and water.
Cocaine use leads to increases in alertness, feelings of well-being and euphoria, increased energy and motor activity, and increased feelings of competence and sexuality.
Analysis of the correlation between the use of 18 various psychoactive substances shows that cocaine use correlates with the use of other "party drugs" (e.g., MDMA, amphetamine), as well as with heroin and benzodiazepines use, and can be considered as a bridge between the use of different groups of drugs.

#### Insufflation

Nasal insufflation (known colloquially as "snorting", "sniffing", or "blowing") is a common method of ingestion of recreational powdered cocaine. The drug coats and is absorbed through the mucous membranes lining the nasal passages. Cocaine's desired euphoric effects are delayed when snorted through the nose by about five minutes. This occurs because cocaine's absorption is slowed by its constricting effect on the blood vessels of the nose. Insufflation of cocaine also leads to the longest duration of its effects (60–90 minutes). When insufflating cocaine, absorption through the nasal membranes is approximately 30–60%
Most banknotes have traces of cocaine on them; this has been confirmed by studies done in several countries. In 1994, the US 9th Circuit Court of Appeals cited findings that in Los Angeles, three out of four banknotes were tainted by cocaine or another illicit drug.
Snuff spoons, hollowed-out pens, cut straws, pointed ends of keys, long fingernails or artificial nails, and tampon applicators are also used to insufflate cocaine. The cocaine typically is poured onto a flat, hard surface and divided into "bumps", "lines", or "rails", and then insufflated. A 2001 study reported that the sharing of straws used to "snort" cocaine can spread blood diseases such as hepatitis C.

##### Cocaine spoon

Historically, snuff spoons were used for cocaine in the 20th century, hence the names "cocaine spoon" and "coke spoon". Some local statutes in the US treat spoons that are too small and thus "unsuited for the typical, lawful uses of a spoon" as drug paraphernalia.

#### Injection

Subjective effects not commonly shared with other methods of administration include a ringing in the ears moments after injection (usually when over 120 milligrams) lasting 2 to 5 minutes including tinnitus and audio distortion. This is colloquially referred to as a "bell ringer". In a study of cocaine users, the average time taken to reach peak subjective effects was 3.1 minutes. The euphoria passes quickly. Aside from the toxic effects of cocaine, there is also the danger of circulatory emboli from the insoluble substances that may be used to cut the drug. As with all injected illicit substances, there is a risk of the user contracting blood-borne infections if sterile injecting equipment is not available or used.

#### Inhalation

##### Cocaine paste

Coca paste (paco, basuco, oxi, pasta) is a crude extract of the coca leaf which contains 40% to 91% cocaine freebase along with companion coca alkaloids and varying quantities of benzoic acid, methanol, and kerosene. The caustic reactions associated with the local application of coca paste prevents its use by oral, intranasal, mucosal, intramuscular, intravenous or subcutaneous routes. Coca paste can only be smoked when combined with a combustible material such as tobacco or cannabis.
Crude cocaine preparation intermediates are marketed as cheaper alternatives to pure cocaine to local markets while the more expensive end product is exported to United States and European markets. Freebase cocaine paste preparations can be smoked. The psychological and physiological effects of the paco are quite severe. Media usually report that it is extremely toxic and addictive. According to a study by Intercambios, media appear to exaggerate the effects of paco. These stereotypes create a sense that nothing can be done to help a paco addict and thus stand in the way of rehabilitation programs.

##### Crack cocaine

Powder cocaine (cocaine hydrochloride) must be heated to a high temperature to be smoked (about 197 °C), and considerable decomposition/burning occurs at these high temperatures. This effectively destroys some of the cocaine and yields a sharp, acrid, and foul-tasting smoke. Cocaine base/crack can be smoked because it vaporizes with little or no decomposition at 98 °C (208 °F), which is below the boiling point of water.

## Contraindications

Cocaine should not be used in individuals with a known allergy or hypersensitivity to the drug or any components of its topical formulation. It is also contraindicated in elderly patients and those with a history of hypertension or cardiovascular disease.

### Pregnancy

Prenatal cocaine exposure (PCE) may occur when a pregnant woman uses cocaine.
Under the former FDA pregnancy category system, cocaine was classified as a Category C drug. Its potential to cause harm to the fetus is not fully known, so it should only be administered to pregnant women if clearly necessary.
Cocaine can act as a teratogen, having various effects on the developing fetus. Some common teratogenic defects caused by cocaine include hydronephrosis, cleft palate, polydactyly, and down syndrome. Cocaine as a drug has a low molecular weight and high water and lipid solubility which enables it to cross the placenta and fetal blood-brain barrier. Because cocaine is able to pass through the placenta and enter the fetus, the fetus' circulation can be negatively affected. With restriction of fetal circulation, the development of organs in the fetus can be impacted, even resulting in intestines developing outside of the fetus' body. Cocaine use during pregnancy can also result in obstetric labor complications such as, placental abruption, preterm birth or delivery, uterine rupture, miscarriage, and stillbirth. Prenatal cocaine exposure may cause subtle cognitive deficits and lower the chance of above-average IQ by age 4, but supportive caregiving can significantly improve outcomes.

### Breastfeeding

Mothers utilizing recreational drugs, such as cocaine, methamphetamines, PCP, and heroin, should not breastfeed.
The March of Dimes said "it is likely that cocaine will reach the baby through breast milk," and advises the following regarding cocaine use during pregnancy:

Cocaine use during pregnancy can affect a pregnant woman and her unborn baby in many ways. During the early months of pregnancy, it may increase the risk of miscarriage. Later in pregnancy, it can trigger preterm labor (labor that occurs before 37 weeks of pregnancy) or cause the baby to grow poorly. As a result, cocaine-exposed babies are more likely than unexposed babies to be born with low birth weight (less than 5.5 lb or 2.5 kg). Low-birthweight babies are 20 times more likely to die in their first month of life than normal-weight babies, and face an increased risk of lifelong disabilities such as mental retardation and cerebral palsy. Cocaine-exposed babies also tend to have smaller heads, which generally reflect smaller brains. Some studies suggest that cocaine-exposed babies are at increased risk of birth defects, including urinary tract defects and, possibly, heart defects. Cocaine also may cause an unborn baby to have a stroke, irreversible brain injury, or a myocardial infarction.

## Adverse effects

### Cardiac complications

Cocaine use can cause serious heart problems like sudden death, heart inflammation, arrhythmias, and heart attacks. It triggers coronary artery spasms, increases blood clot risk, and accelerates atherosclerosis, especially with long-term use. The severity of heart disease often relates to how long and how often cocaine is used. It can also become a serious risk at high doses due to cocaine's blocking effect on cardiac sodium channels.

### Levamisole syndromes

Levamisole is one of the most common adulterants found in illicit cocaine, with studies showing that between 2009 and 2016, 50–70% of all cocaine specimens worldwide contained levamisole, reflecting similar high rates of contamination across North America and Europe. Before trafficking to the United States, the cocaine is frequently adulterated with levamisole. By October 2017, this figure had risen further, with the US Drug Enforcement Administration (DEA) reporting that 87% of seized and analyzed cocaine bricks in the United States contained levamisole, making it the most common adulterant in cocaine at that time.
In the body, levamisole is converted into aminorex, a substance with amphetamine-like stimulant effects and a long duration of action. Levamisole-adulterated cocaine is associated with cocaine- and levamisole-induced vasculitis (CLIV) and cocaine/levamisole-associated autoimmune syndrome (CLAAS). Reagent testing kits can be used to detect the presence of cocaine and levamisole.

#### Levamisole-induced necrosis syndrome

Levamisole-induced necrosis syndrome (LINES) is a complication characterized by necrosis resulting from exposure to levamisole, a medication with immunomodulatory properties. While LINES can occur with levamisole use alone, most reported cases are associated with the use of cocaine adulterated with levamisole as a cutting agent. This syndrome is marked by skin necrosis, often affecting areas such as the ears, face, and extremities, and is thought to result from levamisole's effects on blood vessels and the immune system.

#### Cocaine/levamisole-associated syndromes

The skin necrosis associated with levamisole toxicity ranges from leukocytoclastic vasculitis to occlusive vasculopathy. Several cases of severe agranulocytosis associated with cocaine use have been reported since 2006. With the recently recognized dermal disease, the face and ears are commonly affected, especially the bilateral helices and cheeks. However, there have also been case reports of involvement of the abdomen, chest, lower buttocks and legs.
During the mid-2010s, levamisole was found in most cocaine products available in both the United States and Europe. Levamisole is known to cause an acute condition involving a severe and dangerous lowered white blood cell count, known as agranulocytosis, in cocaine users, and may also accentuate cocaine's effects.
Clinical studies have shown that taking levamisole at doses of 50–200 mg per day can lead to agranulocytosis in approximately 0.08–5% of patients.

##### Cocaine- and levamisole-induced vasculitis

Cocaine- and levamisole-induced vasculitis (CLIV) is often used as an umbrella term for the vasculitic and necrotic complications seen with levamisole-adulterated cocaine, including both LINES and CLAAS.
Cocaine and levamisole-adulterated cocaine (LAC) can cause cocaine-induced vasculitis (CIV) that mimics primary anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), presenting as cocaine-induced midline destructive lesions, LAC vasculopathy, or CIV. These conditions involve immune activation through NETosis and ANCA formation, leading to tissue damage. Diagnosis is challenging due to symptom overlap and undisclosed drug use, making clinical suspicion and drug history essential for proper management.

###### Cocaine/levamisole-associated autoimmune syndrome

The broader cocaine/levamisole-associated autoimmune syndrome (CLAAS) includes LINES as a subset and is also common, but LINES is more specifically and frequently cited in the context of street cocaine adulteration.
Levamisole has become a common additive to illicit cocaine. It is thought to intensify the "high" by releasing dopamine in the brain, acts as a bulking agent, and is a difficult adulterant to recognize. Potential risks of levamisole-laced cocaine include autoimmune disease, neutropenia, arthralgias, retiform purpura, skin necrosis, and fever.

### Mortality

Persons with regular or problematic use of cocaine have a significantly higher mortality rate, and are specifically at higher risk of traumatic deaths and deaths attributable to infectious disease. In 2025, the Liberty House Clinic in the United Kingdom noted that chronic cocaine usage in fact had a higher risk of death than alcoholism.

### Neurotoxicity

Cocaine is considered neurotoxic due to its damaging effects on the brain and nervous system. Research has shown that both acute and chronic cocaine use can lead to significant reductions in cerebral blood flow, disrupt neurovascular interactions, and impair brain function. These changes are associated with nerve injury, cognitive deficits, and an increased risk of cerebrovascular accidents such as strokes. Brain imaging studies consistently report that individuals who misuse cocaine exhibit structural and functional abnormalities compared to non-users, supporting the classification of cocaine as a neurotoxic substance.
Cocaine use damages gray matter in brain regions critical for memory, attention, and emotion, leading to cognitive and behavioral impairments. It also disrupts dopamine levels and blood flow, accelerating brain aging and causing long-term neurological harm.

### Psychiatric symptoms

Cocaine produces a spectrum of psychiatric symptoms including agitation, paranoia, anxiety, irritability, psychosis, hallucinations, delusions, violence, as well as suicidal and homicidal thinking.
A considerable proportion of cocaine addicts exhibit hypomanic personality traits that are ego-syntonic with their pattern of cocaine abuse.
Cocaine intoxication mirrors core traits of narcissism—both involve a dopamine-driven, compulsive drive for reward. Just as cocaine produces a brief high that temporarily enhances the sense of worth, narcissists rely on external admiration to feed an addiction to their self-esteem, resulting in a self-reinforcing feedback cycle.
The misuse of cocaine has a high correlation with suicide. In those who use cocaine, the risk is greatest during the withdrawal phase. Cocaine use has been linked to homicide, with up to 31% of homicide victims testing positive for the drug. In 1989 Fulton County, 40% of homicide victims had cocaine metabolites, especially Black and firearm victims.
A 2020 study found that men with cocaine use disorder have greater difficulty identifying emotional expression in female faces, affecting relationships and suggesting a target for intervention. A 2021 study found that cocaine use disorder impairs emotion recognition, especially for happiness and fear, with improvement after long-term abstinence.
Depression is modestly linked to current drug use in cocaine users but does not clearly predict treatment participation or future use. For people who use cocaine, stress and craving can make each other worse. This may help explain why stress can lead to relapse in people trying to stop using cocaine.

#### Psychosis

Cocaine has a similar potential to induce temporary psychosis with more than half of cocaine abusers reporting at least some psychotic symptoms at some point. Typical symptoms include paranoid delusions that they are being followed and that their drug use is being watched, accompanied by hallucinations that support the delusional beliefs. Delusional parasitosis with formication ('cocaine bugs') is also a fairly common symptom.
Cocaine-induced psychosis shows sensitization toward the psychotic effects of the drug. This means that psychosis becomes more severe with repeated intermittent use.

### Short-term effects

Insufflating (snorting) cocaine commonly causes increased mucus production due to irritation and inflammation of the nasal passages. This irritation leads to symptoms such as a runny nose, nasal congestion, and excessive or thickened mucus.
Acute exposure to cocaine has many effects on humans, including euphoria, increases in heart rate and blood pressure, and increases in cortisol secretion from the adrenal gland. In humans with acute exposure followed by continuous exposure to cocaine at a constant blood concentration, the acute tolerance to the chronotropic cardiac effects of cocaine begins after about 10 minutes, while acute tolerance to the euphoric effects of cocaine begins after about one hour. With excessive or prolonged use, the drug can cause itching, fast heart rate, and paranoid delusions or sensations of insects crawling on the skin. Cocaine can induce psychosis characterized by paranoia, impaired reality testing, hallucinations, irritability, and physical aggression. Cocaine intoxication can cause hyperawareness, hypervigilance, psychomotor agitation, and delirium. Consumption of large doses of cocaine can cause violent outbursts, especially by those with preexisting psychosis. Acute exposure may induce arrhythmia, including atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, and ventricular fibrillation. Acute exposure may also lead to angina, heart attack, and congestive heart failure. Cocaine overdose may cause seizures, abnormally high body temperature and a marked elevation of blood pressure, which can be life-threatening, abnormal heart rhythms, and death. Anxiety, paranoia, and restlessness can also occur, especially during the comedown. With excessive dosage, tremors, convulsions, and increased body temperature are observed.

### Long-term effects

Cocaine is highly addictive and has poor bioavailability when taken orally. Individuals often engage in repeated use by either insufflating it intranasally or converting it to crack cocaine for vaporization. Cocaine's effects last longest when insufflated (60–90 minutes), but the drug itself has a short biological half-life of about 0.7–1.5 hours. Repeated use raises the risk of developing "cocaine nose," referring to severe nasal tissue damage from intranasal use, as well as "crack lung," a condition involving lung tissue damage caused by inhaling crack cocaine.
Cocaine use leads to an increased risk of hemorrhagic and ischemic strokes. Cocaine use also increases the risk of having a heart attack.
Cocaine use also promotes the formation of blood clots. This increase in blood clot formation is attributed to cocaine-associated increases in the activity of plasminogen activator inhibitor, and an increase in the number, activation, and aggregation of platelets.
Cocaine constricts blood vessels, dilates pupils, and increases body temperature, heart rate, and blood pressure. It can also cause headaches and gastrointestinal complications such as abdominal pain and nausea. Chronic users may lose their appetite and experience severe malnutrition, leading to being underweight.
A 2014 study found that increased cocaine use is linked to greater cognitive impairment, particularly in working memory, while reduced or ceased use can lead to partial or full recovery of cognitive function. These findings suggest that some cocaine-related cognitive deficits are reversible, especially if use begins later in life. A 2018 review found little evidence that chronic cocaine use causes widespread cognitive impairment. Exposure to cocaine may lead to the breakdown of the blood–brain barrier.
Cocaine use is frequently associated with involuntary tooth grinding, known as bruxism, which can cause dental attrition and gingivitis. Additionally, stimulants like cocaine, methamphetamine, and even caffeine cause dehydration and dry mouth.

#### Addiction

Cocaine can induce tolerance after a single dose, and repeated use frequently leads to the development of addiction and prolonged craving. Assessment tools like the Obsessive Compulsive Cocaine Use Scale (OCCUS) may be employed to quantify obsessive and compulsive thoughts related to cocaine consumption.
Withdrawal symptoms include disrupted sleep, irritability, depression, and reduced ability to experience pleasure (anhedonia). Chronic nasal use may cause destructive damage to the nasal septum, including cocaine-induced midline destructive lesions (CIMDL). Illicit cocaine is frequently adulterated with substances such as fentanyl, levamisole, or local anesthetics, increasing its toxicity. Concurrent use with alcohol produces cocaethylene, a metabolite that significantly increases the risk of sudden death. According to the Global Burden of Disease Study, cocaine use is responsible for approximately 7,300 deaths annually.
Cocaine abuse can trigger addiction-related structural neuroplasticity in the human brain, although the permanence of such changes remains uncertain. Family history is a known risk factor, as relatives of cocaine users have an increased likelihood of developing cocaine addiction.
A key mechanism involves the overexpression of ΔFosB in the nucleus accumbens, altering transcriptional regulation and reinforcing drug-seeking behavior. Each dose of cocaine raises ΔFosB levels without a known saturation point. This elevation leads to increased brain-derived neurotrophic factor (BDNF) levels, which in turn enhance dendritic branching and spine density in neurons of the nucleus accumbens and prefrontal cortex, potentially persisting for weeks after drug cessation. In transgenic mice engineered to express ΔFosB in the nucleus accumbens and dorsal striatum, heightened behavioral sensitization to cocaine has been observed. These mice self-administer cocaine at lower doses and display a greater propensity for relapse after withdrawal ΔFosB also enhances sensitivity to reward by upregulating the AMPA receptor subunit GluR2 and downregulating the expression of dynorphin.
Cocaine use has also been shown to increase DNA damage in the brains of rodents. During subsequent DNA repair, enduring alterations in chromatin structure may arise, such as DNA methylation and methylation or acetylation of histones at the repair loci. These modifications may result in lasting epigenetic "scars", which are believed to contribute to the persistent epigenetic changes observed in cocaine addiction.

#### Dependence and withdrawal

Cocaine dependence develops after even brief periods of regular cocaine use.
About 25% of adults with attention deficit hyperactivity disorder (ADHD) use cocaine, and 10% develop a cocaine use disorder during their lifetime. Because cocaine use can worsen health outcomes, adults with ADHD should be screened for cocaine use disorder and referred for treatment if needed.
Cocaine-dependent patients with high neuroticism scores are more likely to experience cocaine-induced psychotic symptoms, regardless of other drug use factors, making personality assessment important for risk identification and patient warning.
Cocaine withdrawal symptoms group into two types: depressive (e.g., depression, craving, insomnia) and somatic (e.g., increased appetite, fatigue). Depressive symptoms are linked to worse outcomes like longer depression, treatment, and risky behaviors.

##### Treatment

Because there are no medications with an approved indication for cocaine use disorder, psychosocial treatments are the current standard. Effective approaches include group and individual counseling, cognitive behavioral therapy (CBT), and motivational interviewing (MI). Contingency management (CM)—which rewards patients with vouchers for meeting treatment goals—has proven especially effective, particularly for helping patients achieve initial abstinence from cocaine.

Cocaine Anonymous (CA) is a twelve-step program formed in 18 November 1982 for people who seek recovery from drug addiction. It is patterned very closely after Alcoholics Anonymous (AA), although the two groups are unaffiliated.  While many CA members have been addicted to cocaine, crack, speed or similar substances, CA accepts all who desire freedom from "cocaine and all other mind-altering substances" as members.
Numerous medications have been investigated for use in cocaine dependence, but as of 2015, none of them were considered to be effective. Drugs which help to re-stabilize the glutamate system such as N-acetylcysteine have been proposed for the treatment of addiction to cocaine, nicotine, and alcohol. However, none have sufficient evidence or regulatory approval for routine clinical use, so psychosocial interventions remain the mainstay of treatment.

#### Cocaine nose

"Cocaine nose" or "coke nose" are informal terms that refer to nose disorders resulting from repeated or chronic cocaine use.
About 30% of people who had snorted cocaine at least 25 times but less than daily, and 47% of daily users, reported experiencing nasal irritation, crusting or scabbing, and frequent nosebleeds. Cocaine use should be considered as a potential cause of persistent or unexplained rhinitis, including in adolescent patients.
Because the nose is a prominent facial feature, such visible damage often leads to embarrassment, stigma, and negative reactions from others. As a result, individuals with cocaine-induced nasal damage frequently withdraw from social activities and relationships, leading to social isolation. In many cases, this isolation is not just likely but almost inevitable, as affected individuals may feel unable to face the outside world due to the noticeable and sometimes severe changes to their appearance.
Nose disorders associated with cocaine nose include:

Cocaine-induced midline destructive lesions (CIMDL)
Nasal septum perforation
Palate perforation
Saddle nose

##### Cocaine-induced midline destructive lesions

Cocaine-induced midline destructive lesions (CIMDL) is the progressive destruction of nasal architecture with the erosion of the palate, nasal conchae, and ethmoid sinuses associated with prolonged insufflation, colloquially 'snorting', of cocaine.
Chronic intranasal usage can degrade the cartilage separating the nostrils (the septum nasi), leading eventually to its complete disappearance.

##### Causes

The cause of "cocaine nose" can be traced to the chemical process that occurs when cocaine hydrochloride is insufflated (snorted). As cocaine is absorbed through the nasal mucosa, the remaining hydrochloride component forms a dilute hydrochloric acid. The short half-life of cocaine, combined with binge use, may expose the nasal tissues to this acidic environment more frequently, increasing the risk of irritation and damage.

##### Treatment

For people with cocaine abuse, mild symptoms may resolve completely with total abstinence from cocaine, making early involvement of addiction services essential.
Repair may involve rhinoplasty, which includes creating a new internal lining with nasolabial flaps and restoring support with costal cartilage grafts.
In 2024, Belgian doctors report a rise in patients needing nose reconstruction due to cocaine use, which damages nasal tissue and cartilage; however, few undergo surgery because it requires at least six months of abstinence from cocaine for proper healing.
Some individuals seek plastic surgery to repair or reconstruct nasal damage caused by cocaine use, although surgical outcomes can be complicated by ongoing tissue loss and poor healing. When nasal damage is too severe for reconstruction, a nose prosthesis may be used to restore appearance and quality of life.

## Overdose

According to the European Union Drugs Agency, the estimated minimum lethal dose is 1.2 grams. However, sensitive individuals have died from as little as 30 milligrams applied to mucous membranes-an amount that is 40 times less than the minimum lethal dose. In contrast, addicts may tolerate doses as high as 5 grams per day.
Use of cocaine causes abnormally fast heart rhythms and a marked elevation of blood pressure (hypertension), which can be life-threatening. This can lead to death from acute myocardial infarction, acute respiratory failure (i.e., hypoxemia, with or without hypercapnia), stroke, cerebral hemorrhage, and sudden cardiac arrest. Overdose can also cause acute hepatotoxicity—typically due to toxic metabolites—though most cases resolve quickly; however, fatal outcomes from multiple organ dysfunction syndrome are possible, and there is no specific antidote. Cocaine overdose may result in hyperthermia as stimulation and increased muscular activity cause greater heat production. Heat loss is also inhibited by the cocaine-induced vasoconstriction.
In 2024, drug-related deaths in England and Wales reached their highest level in three decades, with a notable increase in fatalities involving cocaine and experts urging urgent government intervention to address the crisis. Martin Powell, from the charity Transform, which campaigns for the legal regulation of drugs, suggested that the recent rise in cocaine-related deaths in the UK may be due to the increased purity of cocaine, leading users to consume it more frequently and alongside other substances.

## Interactions

### Alcohol

Alcohol interacts with cocaine in vivo to produce cocaethylene, another psychoactive substance which may be substantially more cardiotoxic than either cocaine or alcohol by themselves. In 2024, a systematic review of human studies concluded that, despite some inconsistencies in the findings, the co-use of cocaine and alcohol poses a significantly greater risk of cardiovascular fatalities compared to cocaine use alone. This elevated risk is largely attributed to the formation of cocaethylene, a unique and toxic metabolite produced only when both substances are consumed together. Cocaethylene is associated with an 18- to 25-fold increased risk of sudden death, as well as a higher incidence of myocardial injury and cardiac arrest, underscoring the serious health risks of simultaneous cocaine and alcohol use.

### MAOIs

Monoamine oxidase inhibitors (MAOIs) should not be combined with other psychoactive substances (antidepressants, painkillers, stimulants, including prescribed, OTC and illegally acquired drugs, etc.) except under expert care.

### Opioids

The opioid epidemic now involves more overdose deaths with both opioids and cocaine, especially among non-Hispanic Blacks who are twice as likely to die from combined opioid-stimulant overdoses compared to non-Hispanic whites. Cocaine-related deaths in Blacks are similar to opioid deaths in whites. Risk factors include young age, education, urban living, mental disorders, and stress. It remains unclear if co-use is intentional. Recent studies expand focus beyond heroin to all opioids, reflecting changing overdose patterns.

## Pharmacology

### Pharmacokinetics

The extent of absorption of cocaine into the circulatory system after nasal insufflation is similar to that after oral ingestion. The rate of absorption after nasal insufflation is limited by cocaine-induced vasoconstriction of capillaries in the nasal mucosa. Onset of absorption after oral ingestion is delayed because cocaine is a weak base with a pKa of 8.6, and is thus in an ionized form that is poorly absorbed from the gastric acid and easily absorbed from the alkaline duodenum. The rate and extent of absorption from inhalation of cocaine is similar or greater than with intravenous injection, as inhalation provides access directly to the capillary bed. The delay in absorption after oral ingestion may account for the popular belief that cocaine bioavailability from the stomach is lower than after insufflation. Compared with ingestion, the faster absorption of insufflated cocaine results in quicker attainment of maximum drug effects. Snorting cocaine produces maximum physiological effects within 40 minutes and maximum psychotropic effects within 20 minutes. Physiological and psychotropic effects from nasally insufflated cocaine are sustained for approximately 40–60 minutes after the peak effects are attained.
Cocaine crosses the blood–brain barrier via both a proton-coupled organic cation antiporter and (to a lesser extent) via passive diffusion across cell membranes. As of September 2022, the gene or genes encoding the human proton-organic cation antiporter had not been identified.
Cocaine has a short elimination half-life of 0.7–1.5 hours and is extensively metabolized by plasma esterases and also by liver cholinesterases, with only about 1% excreted unchanged in the urine. The metabolism is dominated by hydrolytic ester cleavage, so the eliminated metabolites consist mostly of benzoylecgonine (BE), the major metabolite, and other metabolites in lesser amounts such as ecgonine methyl ester (EME) and ecgonine. Further minor metabolites of cocaine include norcocaine, p-hydroxycocaine, m-hydroxycocaine, p-hydroxybenzoylecgonine (pOHBE), and m-hydroxybenzoylecgonine.
Depending on liver and kidney functions, cocaine metabolites are detectable in urine between three and eight days. Generally speaking benzoylecgonine is eliminated from someone's urine between three and five days. In urine from heavy cocaine users, benzoylecgonine can be detected within four hours after intake and in concentrations greater than 150 ng/mL for up to eight days later.

### Detection in the body

#### Body fluids

Cocaine and its major metabolites may be quantified in blood, plasma, or urine to monitor for use, confirm a diagnosis of poisoning, or assist in the forensic investigation of a traffic or other criminal violation or sudden death. Most commercial cocaine immunoassay screening tests cross-react appreciably with the major cocaine metabolites, but chromatographic techniques can easily distinguish and separately measure each of these substances. When interpreting the results of a test, it is important to consider the cocaine usage history of the individual, since a chronic user can develop tolerance to doses that would incapacitate a cocaine-naive individual, and the chronic user often has high baseline values of the metabolites in his system. Cautious interpretation of testing results may allow a distinction between passive or active usage, and between smoking versus other routes of administration.

#### Hair

Hair analysis can detect cocaine metabolites in regular users until after the sections of hair grown during the period of cocaine use are cut or fall out.

### Pharmacodynamics

Cocaine acts as a serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI). Cocaine increases levels of serotonin, norepinephrine, and dopamine in the synaptic cleft, leading to heightened post-synaptic activation, with dopamine contributing to euphoria and arousal, and the other monoamines enhancing additional effects.
The pharmacodynamics of cocaine involve the complex relationships of neurotransmitters (inhibiting monoamine uptake in rats with ratios of about: serotonin:dopamine = 2:3, serotonin:norepinephrine = 2:5). The most extensively studied effect of cocaine on the central nervous system is the blockade of the dopamine transporter protein. Dopamine neurotransmitter released during neural signaling is normally recycled via the transporter; i.e., the transporter binds the transmitter and pumps it out of the synaptic cleft back into the presynaptic neuron, where it is taken up into storage vesicles. Cocaine binds tightly at the dopamine transporter forming a complex that blocks the transporter's function. The dopamine transporter can no longer perform its reuptake function, and thus dopamine accumulates in the synaptic cleft. The increased concentration of dopamine in the synapse activates post-synaptic dopamine receptors, which makes the drug rewarding and promotes the compulsive use of cocaine.
Cocaine affects certain serotonin (5-HT) receptors; in particular, it has been shown to antagonize the 5-HT3 receptor, which is a ligand-gated ion channel. An overabundance of 5-HT3 receptors is reported in cocaine-conditioned rats, though 5-HT3's role is unclear. The 5-HT2 receptor (particularly the subtypes 5-HT2A, 5-HT2B and 5-HT2C) are involved in the locomotor-activating effects of cocaine.
Cocaine has been demonstrated to bind as to directly stabilize the DAT transporter on the open outward-facing conformation. Further, cocaine binds in such a way as to inhibit a hydrogen bond innate to DAT. Cocaine's binding properties are such that it attaches so this hydrogen bond will not form and is blocked from formation due to the tightly locked orientation of the cocaine molecule. Research studies have suggested that the affinity for the transporter is not what is involved in the habituation of the substance so much as the conformation and binding properties to where and how on the transporter the molecule binds.
Conflicting findings have challenged the widely accepted view that cocaine functions solely as a reuptake inhibitor. To induce euphoria an intravenous dose of 0.3-0.6 mg/kg of cocaine is required, which blocks 66-70% of DAT in the brain. Re-administering cocaine beyond this threshold does not significantly increase DAT occupancy but still results in an increase of euphoria which cannot be explained by reuptake inhibition alone. This discrepancy is not shared with other dopamine reuptake inhibitors like bupropion, sibutramine, mazindol or tesofensine, which have similar or higher potencies than cocaine as dopamine reuptake inhibitors. Furthermore, a similar response-occupancy discrepancy has been observed with methylphenidate, which also stabilizes the dopamine transporter in an open outward-facing conformation. These findings have evoked a hypothesis that cocaine may also function as a so-called "DAT inverse agonist" or "negative allosteric modifier of DAT" resulting in dopamine transporter reversal, and subsequent dopamine release into the synaptic cleft from the axon terminal in a manner similar to but distinct from amphetamines.
Sigma receptors are affected by cocaine, as cocaine functions as a sigma ligand agonist. Further specific receptors it has been demonstrated to function on are NMDA and the D1 dopamine receptor.
Cocaine also blocks sodium channels, thereby interfering with the propagation of action potentials; thus, like lignocaine and novocaine, it acts as a local anesthetic. It also functions on the binding sites to the dopamine and serotonin sodium dependent transport area as targets as separate mechanisms from its reuptake of those transporters; unique to its local anesthetic value which makes it in a class of functionality different from both its own derived phenyltropanes analogues which have that removed. In addition to this, cocaine has some target binding to the site of the κ-opioid receptor. Cocaine also causes vasoconstriction, thus reducing bleeding during minor surgical procedures. Recent research points to an important role of circadian mechanisms and clock genes in behavioral actions of cocaine.
Cocaine is known to suppress hunger and appetite by increasing co-localization of sigma σ1R receptors and ghrelin GHS-R1a cell surface receptors, thereby increasing ghrelin-mediated signaling of satiety and possibly via other effects on appetitive hormones.
Cocaine effects, further, are shown to be potentiated for the user when used in conjunction with new surroundings and stimuli, and otherwise novel environs.

## Chemistry

### Forms

In its purest form, cocaine is a white, pearly powder. As a tropane alkaloid, cocaine is a weak base and readily forms salts when combined with acids. The most commonly encountered form is the hydrochloride (HCl) salt, although other salts such as the sulfate (SO42−) and nitrate (NO3−) are occasionally observed. The solubility of these salts varies depending on their polarity; the hydrochloride salt is polar and highly soluble in water.

### Synthesis

#### Total synthesis

The first structure elucidation and total synthesis of the cocaine molecule was accomplished by Richard Willstätter in 1898. Willstätter's synthesis involved constructing the cocaine structure from simpler precursors, notably via the intermediate tropinone. Subsequent significant contributions to understanding the synthetic pathway and stereochemistry were made by Robert Robinson and Edward Leete.
Cocaine contains four chiral centers (1R, 2R, 3S, and 5S), two of which are configurationally dependent, resulting in eight possible stereoisomers. The formation of inactive stereoisomers, along with various synthetic by-products, limits both the yield and purity of the final product.
Although the chemical synthesis of cocaine is technically feasible, it is generally considered impractical due to its high cost, low efficiency, and challenges in stereoselective synthesis compared to extraction from natural plant sources. While domestic clandestine laboratories could theoretically reduce reliance on offshore production and international smuggling—as seen with illicit methamphetamine—manufacture and synthetic production of cocaine remains rare. Large-scale commercial synthesis has not been explored.

#### Biosynthesis

The biosynthesis of cocaine is the natural metabolic process by which the coca plant (Erythroxylum species) produces cocaine, a tropane alkaloid, through a multi-step enzymatically catalyzed pathway beginning with ornithine or arginine and culminating in the formation of the cocaine metabolite benzoylecgonine.
Large-scale biosynthesis of cocaine is unexplored.
The biosynthesis of cocaine has long attracted the attention of biochemists and organic chemists.  This interest is partly motivated by the strong physiological effects of cocaine, but a further incentive was the unusual bicyclic structure of the molecule.  The biosynthesis can be viewed as occurring in two phases, one phase leading to the N-methylpyrrolinium ring, which is preserved in the final product.  The second phase incorporates a C4 unit with formation of the bicyclic tropane core.

#### GMO synthesis

In 2022, a GMO produced N. benthamiana were discovered that were able to produce 25% of the amount of cocaine found in a coca plant.
However, since N. benthamiana also naturally contains nicotine, separating the cocaine from nicotine and related alkaloids would be challenging.

### Field analysis

Personal cards-including ID cards and driver's licenses-are frequently swabbed by inspectors to detect drug residue, as these items are commonly used to prepare lines of cocaine. Swabbing can reveal traces of cocaine or other illicit substances, providing evidence of recent drug handling or use. This practice may be employed during security checks at border crossings.
A Newsbeat investigation found that "cocaine torches" used by UK police to detect cocaine use are ineffective on typical street cocaine, as independent lab tests showed they fail to make the drug fluoresce. Experts and drug charities criticized the devices, warning they can give false positives and waste resources, while police forces defended their use as a deterrent. The manufacturer says the torches only work on much purer forms of cocaine than are found on the street.
Cocaine may be detected by law enforcement using the Scott reagent. The test can easily generate false positives for common substances and must be confirmed with a laboratory test.
Approximate cocaine purity can be determined using 1 mL 2% cupric sulfate pentahydrate in dilute HCl, 1 mL 2% potassium thiocyanate and 2 mL of chloroform. The shade of brown shown by the chloroform is proportional to the cocaine content. This test is not cross sensitive to heroin, methamphetamine, benzocaine, procaine and a number of other drugs but other chemicals could cause false positives.

## Society and culture

Both the pharmaceutical supply chain and the illicit supply chain obtain cocaine from coca cultivated in Latin America, but they operate under very different controls and oversight. In Peru, for example, legal coca cultivation is monopolized by the state company National Coca Company (ENACO), yet approximately 90% of coca leaves produced in the country are diverted to illegal actors for cocaine manufacturing. As a result, these illicit coca crops are a primary target of ongoing government-led coca eradication efforts.
Cocaine is prohibited in competition for athletes by the World Anti-Doping Agency (WADA), which lists it as a stimulant on its International Standard for the Prohibited List.

### Street names

Cocaine is sometimes referred to on the street as blow, coca, coke, crank, flake, snow, or soda cot. Slang terms for free base cocaine include crack or rock.
Fishscale cocaine, from fish + scale, is named for its shiny, yellowish flakes that resemble fish scales—distinct from the dull white appearance of standard cocaine powder.

### Legal status

The production, distribution, and sale of cocaine products is restricted (and illegal in most contexts) in most countries as regulated by the Single Convention on Narcotic Drugs, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. In the United States the manufacture, importation, possession, and distribution of cocaine are additionally regulated by the 1970 Controlled Substances Act.
Some countries, such as Bolivia, Colombia, and Peru, permit the cultivation of coca leaf for traditional consumption by the local indigenous population, but nevertheless, prohibit the production, sale, and consumption of cocaine. The provisions as to how much a coca farmer can yield annually is protected by laws such as the Bolivian Cato accord. In addition, some parts of Europe, the United States, and Australia allow processed cocaine for medicinal uses only.

#### Australia

Cocaine is a Schedule 8 controlled drug in Australia under the Poisons Standard. It is the second most popular illicit recreational drug in Australia behind cannabis.
In Western Australia under the Misuse of Drugs Act 1981, 4.0g of cocaine is the amount of prohibited drugs determining a court of trial, 2.0g is the amount of cocaine required for the presumption of intention to sell or supply, and 28.0g is the amount of cocaine required for purposes of drug trafficking.

#### United States

The US federal government instituted a national drug labelling requirement for cocaine and cocaine-containing products through the Pure Food and Drug Act of 1906. The next important federal regulation was the Harrison Narcotics Tax Act of 1914. While this act is often seen as the start of prohibition, the act itself was not actually a prohibition on cocaine, but instead it set up a regulatory and licensing regime. The Harrison Act did not recognize addiction as a treatable condition and therefore the therapeutic use of cocaine, heroin, or morphine to such individuals was outlawed –  leading a 1915 editorial in the journal American Medicine to remark that the addict "is denied the medical care he urgently needs, open, above-board sources from which he formerly obtained his drug supply are closed to him, and he is driven to the underworld where he can get his drug, but of course, surreptitiously and in violation of the law." The Harrison Act left manufacturers of cocaine untouched so long as they met certain purity and labeling standards. Despite that cocaine was typically illegal to sell and legal outlets were rarer, the quantities of legal cocaine produced declined very little. Legal cocaine quantities did not decrease until the Jones–Miller Act of 1922 put serious restrictions on cocaine manufactures.
Before the early 1900s, newspapers primarily portrayed addiction (rather than violence or crime) as the main problem caused by cocaine use, and depicted cocaine users as upper or middle class White people. In 1914, The New York Times published an article titled "Negro Cocaine 'Fiends' Are a New Southern Menace," portraying Black people who used cocaine as dangerous and able to withstand wounds that would normally be fatal. The Anti-Drug Abuse Act of 1986 mandated the same prison sentences for distributing 500 grams of powdered cocaine and just 5 grams of crack cocaine. In the National Survey on Drug Use and Health, white respondents reported a higher rate of powdered cocaine use, and Black respondents reported a higher rate of crack cocaine use.

### Prevalence and trends

Cocaine production, seizures, and use all reached record levels in 2023, making it the world's fastest-growing illicit drug market. Seizures rose by 68% from 2019 to 2023, while the number of users increased from 17 million in 2013 to 25 million in 2023, according to the UNODC World Drug Report 2025.
The report further states that Western Europe's cocaine market is rapidly expanding, resulting in increased violence driven by traffickers, including organized criminal groups from the Western Balkans. Concurrently, record levels of cocaine production have enabled traffickers to enter new markets across Asia and Africa, reflecting the expanding global reach of cocaine trafficking.
The U.S. is the world's largest consumer of cocaine, while South America, as a continent, ranks third in terms of consumer market size. Europe ranks cocaine as the second most commonly used illicit drug.
Cocaine is among the most widely consumed recreational stimulants worldwide.

### Impact

#### Impact of illicit cocaine

##### Impact on impoverished communities

In countries where cocaine is illicitly produced, an intermediate product known as cocaine paste—often referred to as "poor man's cocaine"—is frequently smoked in impoverished communities. This substance is favored in these areas primarily because it is inexpensive and more accessible than refined cocaine. However, the use of cocaine paste poses severe health risks. During its production, various toxic chemicals are used to extract coca alkaloids from the coca leaves. Many of these hazardous substances, such as solvents and acids, remain in the paste after processing. When the paste is smoked, individuals are exposed not only to the addictive effects of the drug itself but also to the dangerous residual chemicals, which can cause significant harm to the lungs, nervous system, and overall health. This combination of affordability, accessibility, and toxicity makes cocaine paste particularly damaging to vulnerable populations in cocaine-producing regions.

##### Environmental impact

Most of the world's cocaine is produced in South America, particularly in the Andean region. The environmental destruction caused by the production of cocaine has been well documented, with reports made the UN and other government bodies. Due to the illegal nature of coca production, farmers make little effort in soil conservation and sustainability practices as seen in the high mobility and short life of coca plots in Colombia.
One of the major implications of cocaine production is deforestation as large areas of forest are cleared for coca cultivation. The UNODC approximated that 97,622 hectares of primary forest were cleared for coca cultivation during 2001–2004 in the Andean region. This further causes habitat destruction, especially in biodiversity hotspots, areas rich in a variety of species. Such areas are chosen for coca cultivation due to their remote locations, minimising chances of detection. Deforestation impacts soil erosion which further inhibits the survival of native species.
The use of pesticides can also severely affect the environment. Farmers are able to use unregulated and highly toxic pesticides due to the clandestine nature of drug production. The use of such pesticides can have both direct and indirect effects on the ecosystem. Where lethal levels of exposure directly cause the death of fauna, which is further carried up the food chain where secondary feeders who consume the poisoned animals are also impacted. Furthermore, non-lethal levels of exposure can also cause weaker immune system development and neurological issues, further increasing mortality rates.

##### Impact of illicit cocaine trade

Cocaine is extremely expensive on the black market, with prices rising sharply at each distribution level—often more than its weight in gold.

###### Latin America

Drug war policies in Latin America and the Caribbean have led to more violence, higher incarceration rates, health crises, and deeper poverty, while undermining trust in institutions and worsening inequality. There is increasing support for shifting toward drug policies that focus on sustainable development and human rights instead of punitive measures.

###### West Africa

Cocaine trafficking in West Africa has become closely linked with the activities of several terrorist organizations.

#### Impact of enforcement

##### Impact of coca eradication

In December 2000, Dutch journalist Marjon van Royen found that "because the chemical is sprayed in Colombia from planes on inhabited areas, there have been consistent health complaints [in humans]. Burning eyes, dizziness and respiratory problems being most frequently reported." In some areas, 80 percent of the children of the indigenous community fell sick with skin rashes, fever, diarrhoea and eye infections. Because the glyphosate is sprayed from the air, there is a much higher chance of human error when spraying suspected illegal coca plantations. In many cases the wrong fields are sprayed, resulting in not only a total loss of the farmer's crop- but the loss of that field altogether as nothing will grow where the herbicide has been sprayed. Though official documentation of the health effects of glyphosate spraying in Colombia are virtually non-existent, neighbouring Ecuador has conducted studies to determine the cause of mysterious illnesses amongst people living along the border of Colombia and has since demanded that no aerial sprayings occur within 10 km of the border because of the damages caused to the people, animals and environment in that area. In 2015, Colombia announced a ban on using glyphosate in these programs due to concerns about human toxicity of the chemical.

##### Impact of interdiction

The Consolidated Counterdrug Database (CCDB) is a U.S. government dataset created in the 1990s that compiles vetted data on cocaine trafficking and seizures in the Western Hemisphere "transit zone," involving 26 U.S. agencies and 20 foreign partners. It provides a highly reliable, conservative record of cocaine movements and interdiction efforts, revealing that despite large seizures, interdiction captures only a small fraction of trafficking events and has minimal impact on U.S. cocaine prices. The CCDB challenges optimistic views of drug interdiction effectiveness and underscores the need for new policy approaches, yet remains underutilized in research despite being unclassified.

## Research

Cocaine haptens are chemically modified derivatives of cocaine that retain key immunogenic features, allowing them to be attached to carrier proteins such as keyhole limpet hemocyanin or bovine serum albumin. This enables the immune system to recognize cocaine and produce anti-cocaine antibodies, which can bind cocaine in the bloodstream and prevent it from reaching the brain, thereby blocking its psychoactive effects.
The cocaine esterase enzyme and redesigned versions of it have been studied as a potential treatment for cocaine addiction in humans.
Coca tea has been explored as a supportive treatment for cocaine dependence. A study in Lima, Peru, found that using coca leaf infusion along with counseling reduced relapse rates and significantly increased the duration of abstinence among addicted individuals, suggesting that this approach may help prevent relapse during treatment.
Recent research has also examined the use of prescription psychostimulants for cocaine dependence, following the Self-Medication Hypothesis. This hypothesis suggests that some individuals use cocaine to address underlying neurochemical or psychological issues. While some studies indicate that psychostimulant therapy may reduce cocaine use and cravings, the evidence is mixed and further research is needed.
In animal studies, nicotine exposure in mice increases the likelihood of later cocaine use, with clear molecular changes in the brain. These findings mirror human epidemiological data showing a link between nicotine use and increased risk of later cannabis and cocaine use, as well as other substances. Similarly, in rats, alcohol consumption raises the probability of later cocaine addiction and is associated with changes in the brain's reward system. Human studies also show that alcohol use increases the risk of transitioning from cocaine use to addiction.
Experimentally, cocaine injections can be delivered to animals such as fruit flies to study the mechanisms of cocaine addiction.

### Cocaine vaccines

#### Calixcoca

Calixcoca is an experimental vaccine to treat cocaine and crack cocaine addiction. It has been in development since 2015 by the Federal University of Minas Gerais (UFMG) in Brazil.

#### TA-CD

TA-CD is a vaccine developed by the Xenova Group and designed to negate the effects of cocaine, making it suitable for use in treatment of addiction. It is created by combining norcocaine with inactivated cholera toxin.

## History

Coca leaves have been used by indigenous South Americans for thousands of years, both as a stimulant and for medicinal purposes.
When the Spanish arrived in South America, they initially banned coca but soon legalized and taxed it after seeing its importance to local labor. The active ingredient, cocaine, was first isolated in 1855 by Friedrich Gaedcke and later refined by Albert Niemann, who named it "cocaine." In the late 1800s, cocaine became popular in Western medicine as a local anesthetic and was widely used in various products, including drinks and remedies. and James Leonard Corning demonstrated peridural anesthesia. However, due to its toxic effects and potential for abuse, safer alternatives eventually replaced it in medical practice.
Large-scale coca cultivation and cocaine production occurred in Taiwan Asia, in Taiwan (then known as Formosa) and Java (today part of Indonesia) before World War II.
Since the 1980s, the cocaine trade was dominated by centralized, hierarchical drug cartels such as Medellín and Cali, along with their successors and early FARC factions. By the early 2000s, this model fragmented into a diverse network of global trafficking links, allowing South American cocaine production to easily supply markets in Europe, Africa, Asia, and Oceania through various routes.

## Etymology

The word cocaine derives from French  Cocaïne, from Spanish  coca, ultimately from Quechua  kúka.
`,
};
